Laura Jean Havrilesky | Scholars@Duke

Laura Jean Havrilesky
Professor of Obstetrics and Gynecology

I am interested in using health economic models to inform decisions related to gynecologic cancers. Specific models have addressed the decision to administer intraperitoneal chemotherapy for newly diagnosed advanced ovarian cancer following optimal cytoreduction, the choice of chemotherapy regimen for recurrent platinum-sensitive ovarian cancer, and the exploration of screening strategies for ovarian cancer. The ovarian cancer screening model examines the effects of test cost, sensitivity, specificity, and screen frequency on ovarian cancer mortality, the lifetime false positive rate of testing, the positive predictive value of the test, and its cost effectiveness. This type of model is potentially useful in informing the design trials of novel screening tests for ovarian cancer. I am also conducting a prospective study to quantify the effects of screening for, diagnosis of, and treatment for ovarian cancer on the quality of life of women.

Current Research Interests

I am a gynecologic oncologist with an interest in health outcomes and patient preferences. My group has performed several prospective studies of patient preferences regarding the side effects of chemotherapy, surgery, and radiation therapy treatments for ovarian and cervical cancer. We have developed a number of health outcomes models to inform decisions related to gynecologic cancers, including screening, diagnostic testing, and treatment decisions for endometrial, cervical, and ovarian cancer. I currently serve on NRG Oncology’s Patient Centered Outcomes Research Committee and am co-chair of the Comparative Effectiveness Subcommittee for the NRG.

Current Appointments & Affiliations

Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2014
Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2019
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1995

Contact Information

25172 Morris Bldg, Durham, NC 27710
Box 3079 Med Ctr, Durham, NC 27710
havri001@mc.duke.edu (919) 684-0188

Background
Education, Training, & Certifications
- Gynecology Oncology Fellowship, Obstetrics And Gynecology, Duke University School of Medicine 1999 - 2002
- Residency, Obstetrics And Gynecology, Duke University 1995 - 1999
- M.D., Duke University 1995
Previous Appointments & Affiliations
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2010 - 2014
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2008 - 2010
- Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2002 - 2008
- Associate in the Department of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 1999 - 2002
Leadership & Clinical Positions at Duke
- Associate Chair, Quality, Safety and Peer Review Committee for Obstetrics and Gynecology; 2018-present
  
  Chair, Gynecology Peer Review Committee 2018-present
  
  Director of Resident Research for Obstetrics and Gynecology; 2016-present
Academic Positions Outside Duke
- Member, Gynecologic Cancer Guideline Advisory Group, American Society of Clinical Oncology. 2020 - 2021
- Co-Chair, Comparative Effectiveness Subcommittee, NRG Oncology. 2017 - 2021
- Co-Chair, Payment Reform Taskforce, Society of Gynecologic Oncology. 2016 - 2019
- Member, Patient-Centered Outcomes Committee, NRG Oncology. 2015 - 2021
Recognition
Awards & Honors
- Top Reviewer. Gynecologic Oncology. 2011
- Charles A. Hunter, Jr. Prize Thesis Award. American Gynecological and Obstetrical Society. 2007
Research
Selected Grants
- Gynecological Cancer Center of Excellence (GYN-COE) Tissue and Data Acquisition Network (TDAN) with Duke University awarded by Henry M. Jackson Foundation 2022 - 2023
- Comparative Modeling for the Prevention and Control of Uterine Cancer awarded by Columbia University 2021 - 2022
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by Henry M. Jackson Foundation 2016 - 2022
- Intraluminal tumor cells and endometrial cancer prognosis awarded by Ohio State University 2020 - 2021
- Cancer Tx with a PARP Inhibitor VS Standard awarded by TESARO 2017 - 2020
- Women with BRCA-mutated Advanced Stage Ovarian Cancer awarded by AstraZeneca LP 2017 - 2019
- Assessing the relevance of weighted values in the ASCO value framework in ovarian cancer patients awarded by Gynecologic Oncology Group 2016 - 2017
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by Henry M. Jackson Foundation 2016 - 2017
- Ovarian Cancer Patient-Centered Decision Aid awarded by University of California - Irvine 2013 - 2016
- A Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope with Disease Recurrence awarded by Foundation for Women's Cancer 2014 - 2016
- Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer awarded by Agency for Healthcare Research and Quality 2010 - 2012
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by United States Army Medical Research and Materiel Command 2010 - 2011
- Decision Analysis on Screening for Cervical Cancer awarded by Agency for Healthcare Research and Quality 2007 - 2008
- Genomics Tests for Ovarian Cancer Detection and Management awarded by Agency for Healthcare Research and Quality 2005 - 2006
- Management of Adnexal Mass awarded by Agency for Healthcare Research and Quality 2004 - 2006
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Albright, Benjamin B., Quetrell D. Heyward, Alaattin Erkanli, Andrew P. Loehrer, Evan R. Myers, Laura J. Havrilesky, and Haley A. Moss. “Geographic variation in the rate and route of hysterectomy for benign disease in the USA: A retrospective cross-sectional study.” Bjog, May 2, 2023. https://doi.org/10.1111/1471-0528.17509.
    Full Text Link to Item
  - Albright, Benjamin B., Tressa Ellett, Hope E. Knochenhauer, Emily C. Goins, Karen A. Monuszko, Samantha J. Kaplan, Rebecca A. Previs, Haley A. Moss, Laura J. Havrilesky, and Brittany A. Davidson. “Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.” Bjog 130, no. 5 (April 2023): 443–53. https://doi.org/10.1111/1471-0528.17374.
    Full Text Link to Item
  - Watson, Catherine H., Daniel Spinosa, Taylor Hayes, Amelia Scott, Louise Jackson, Julie K. Thacker, Karen L. Sherman, Haley A. Moss, Laura J. Havrilesky, and J Leah McNally. “A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients.” J Low Genit Tract Dis 27, no. 2 (April 1, 2023): 120–24. https://doi.org/10.1097/LGT.0000000000000723.
    Full Text Link to Item
  - Albright, Benjamin B., Elizabeth Wignall, Rex C. Bentley, Laura J. Havrilesky, Rebecca A. Previs, and Kyle C. Strickland. “BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.” Int J Gynecol Pathol 42, no. 1 (January 1, 2023): 83–88. https://doi.org/10.1097/PGP.0000000000000855.
    Full Text Link to Item
  - Salinaro, Julia R., Nicole Zanolli, Tracy Truong, Laura J. Havrilesky, and Brittany A. Davidson. “Implementing guidelines for risk-stratified thromboprophylaxis among gynecologic oncology patients: A quality improvement initiative.” Gynecol Oncol 168 (January 2023): 144–50. https://doi.org/10.1016/j.ygyno.2022.11.016.
    Full Text Link to Item
  - Peters, Pamela N., Julia M. Moyett, Brittany A. Davidson, Sarah Cantrell, Sara E. Bliss, and Laura J. Havrilesky. “Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction.” Gynecol Oncol 167, no. 3 (December 2022): 523–31. https://doi.org/10.1016/j.ygyno.2022.10.013.
    Full Text Link to Item
  - Monuszko, Karen A., Laura J. Fish, Dorinda Sparacio, Christina Lizaso, Kathryn Burn, Natalie E. Wickenheisser, Larissa A. Meyer, Shelby D. Reed, Brittany A. Davidson, and Laura J. Havrilesky. “Understanding the needs and perspectives of ovarian cancer patients when considering PARP inhibitor maintenance therapy: Findings from two online community events.” Gynecol Oncol Rep 43 (October 2022): 101050. https://doi.org/10.1016/j.gore.2022.101050.
    Full Text Link to Item
  - Casablanca, Yovanni, Guisong Wang, Heather A. Lankes, Chunqiao Tian, Nicholas W. Bateman, Caela R. Miller, Nicole P. Chappell, et al. “Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.” Cancers (Basel) 14, no. 17 (August 23, 2022). https://doi.org/10.3390/cancers14174070.
    Full Text Link to Item
  - Modesitt, Susan C., Laura J. Havrilesky, Rebecca A. Previs, J. Alejandro Rauh-Hain, J. Michael Straughn, Jamie N. Bakkum-Gamez, Katherine C. Fuh, and David E. Cohn. “Ridiculously good writing: How to write like a pro and publish like a boss.” Gynecol Oncol Rep 42 (August 2022): 101024. https://doi.org/10.1016/j.gore.2022.101024.
    Full Text Link to Item
  - Rodriguez, Isabel V., Paige McKeithan Cisa, Karen Monuszko, Julia Salinaro, Ashraf S. Habib, J Eric Jelovsek, Laura J. Havrilesky, and Brittany Davidson. “Development and Validation of a Model for Opioid Prescribing Following Gynecological Surgery.” Jama Netw Open 5, no. 7 (July 1, 2022): e2222973. https://doi.org/10.1001/jamanetworkopen.2022.22973.
    Full Text Link to Item
  - Hendrickson, Whitney K., Laura Havrilesky, and Nazema Y. Siddiqui. “Cost-effectiveness of bacteriuria screening before urogynecologic surgery.” Am J Obstet Gynecol 226, no. 6 (June 2022): 831.e1-831.e12. https://doi.org/10.1016/j.ajog.2021.11.1375.
    Full Text Link to Item
  - Goins, Emily C., Jeremy M. Weber, Tracy Truong, Haley A. Moss, Rebecca A. Previs, Brittany A. Davidson, and Laura J. Havrilesky. “Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database.” Gynecol Oncol 165, no. 2 (May 2022): 309–16. https://doi.org/10.1016/j.ygyno.2022.01.030.
    Full Text Link to Item
  - Albright, Benjamin B., Ling Chen, Laura J. Havrilesky, Haley A. Moss, and Jason D. Wright. “Out-of-network bills among privately insured patients undergoing hysterectomy.” Am J Obstet Gynecol 226, no. 4 (April 2022): 543.e1-543.e45. https://doi.org/10.1016/j.ajog.2021.11.027.
    Full Text Link to Item
  - Davidson, Brittany A., Jeremy M. Weber, Karen A. Monuzsko, Tracy Truong, Laura J. Havrilesky, and Haley A. Moss. “Evaluation of Surgical Morbidity After Hysterectomy During an Obesity Epidemic.” Obstet Gynecol 139, no. 4 (April 1, 2022): 589–96. https://doi.org/10.1097/AOG.0000000000004699.
    Full Text Link to Item
  - Watson, Catherine H., Karen Monuszko, Sarah Freeman, Kelli Kurtovic, Brittany A. Davidson, and Laura J. Havrilesky. “Reducing non-surgical readmissions on a gynecologic oncology service.” Gynecol Oncol 165, no. 1 (April 2022): 4–10. https://doi.org/10.1016/j.ygyno.2022.01.004.
    Full Text Link to Item
  - Albright, Benjamin B., Roni Nitecki, Fumiko Chino, Junzo P. Chino, Laura J. Havrilesky, Emeline M. Aviki, and Haley A. Moss. “Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States.” Am J Obstet Gynecol 226, no. 3 (March 2022): 384.e1-384.e13. https://doi.org/10.1016/j.ajog.2021.09.034.
    Full Text Link to Item
  - Davidson, Brittany A., Laura J. Havrilesky, and Carolyn Lefkowitz. “Opportunities to Advance the Delivery of High-Quality, Goal-Concordant End-of-Life Care in Ovarian Cancer.” Jco Oncol Pract 18, no. 3 (March 2022): 161–63. https://doi.org/10.1200/OP.21.00699.
    Full Text Link to Item
  - Reid, Hadley W., Gloria Broadwater, Mary Katherine Montes de Oca, Bharathi Selvan, Oluwadamilola Fayanju, Laura J. Havrilesky, and Brittany A. Davidson. “Distress screening in endometrial cancer leads to disparity in referral to support services.” Gynecol Oncol 164, no. 3 (March 2022): 622–27. https://doi.org/10.1016/j.ygyno.2022.01.001.
    Full Text Link to Item
  - Davidson, Brittany A., Allison M. Puechl, Catherine H. Watson, Stephanie Lim, Luke Gatta, Karen Monuszko, Kerry Drury, et al. “Promoting timely goals of care conversations between gynecologic cancer patients at high-risk of death and their providers.” Gynecol Oncol 164, no. 2 (February 2022): 288–94. https://doi.org/10.1016/j.ygyno.2021.12.009.
    Full Text Link to Item
  - Wong, Janice, Pius Mulamira, Jessica Arizu, Mariam Nabwire, Dorothy Mugabi, Sarah Nabulime, Dorine Driwaru, et al. “Standardization of caregiver and nursing perioperative care on gynecologic oncology wards in a resource-limited setting.” Gynecol Oncol Rep 39 (February 2022): 100915. https://doi.org/10.1016/j.gore.2021.100915.
    Full Text Link to Item
  - Zanolli, Nicole C., Luke A. Gatta, Laura Fish, Margaret Falkovic, Amelia Lorenzo, Allison M. Puechl, Laura J. Havrilesky, and Brittany Davidson. “A Qualitative Assessment of Patient Experience following Systematic Implementation of Goals of Care Conversations in the Ambulatory Gynecologic Oncology Setting.” Palliat Med Rep 3, no. 1 (2022): 308–15. https://doi.org/10.1089/pmr.2022.0040.
    Full Text Link to Item
  - Montes de Oca, Mary Katherine, Benjamin B. Albright, Angeles Alvarez Secord, Laura J. Havrilesky, and Haley A. Moss. “Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.” Int J Gynecol Cancer 31, no. 12 (December 2021): 1549–56. https://doi.org/10.1136/ijgc-2021-002884.
    Full Text Link to Item
  - Albright, Benjamin B., Evan R. Myers, Haley A. Moss, Emily M. Ko, Sarita Sonalkar, and Laura J. Havrilesky. “Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.” Am J Obstet Gynecol 225, no. 5 (November 2021): 513.e1-513.e19. https://doi.org/10.1016/j.ajog.2021.05.031.
    Full Text Link to Item
  - Chapman, Brittany M., Jui-Chen Yang, Juan Marcos Gonzalez, Laura Havrilesky, Shelby D. Reed, and E Shelley Hwang. “Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.” Jco Oncol Pract 17, no. 11 (November 2021): e1639–48. https://doi.org/10.1200/OP.20.00614.
    Full Text Link to Item
  - Huang, Allan B., Jenny Wu, Ling Chen, Benjamin B. Albright, Rebecca A. Previs, Haley A. Moss, Brittany A. Davidson, Laura J. Havrilesky, Alexander Melamed, and Jason D. Wright. “Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review.” Gynecol Oncol Rep 38 (November 2021): 100887. https://doi.org/10.1016/j.gore.2021.100887.
    Full Text Link to Item
  - Gonzalez, Rafael, Andrew Dunn, Logan Williams, Jeremy Weber, Alaattin Erkanli, Laura J. Havrilesky, and Maria Angelica Selim. “Histopathology after lidocaine/prilocaine cream administration for vulvar biopsy.” J Cutan Pathol 48, no. 10 (October 2021): 1239–45. https://doi.org/10.1111/cup.14018.
    Full Text Link to Item
  - Moss, Haley A., Jessica A. Perhanidis, Laura J. Havrilesky, and Angeles Alvarez Secord. “Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.” Gynecol Oncol 163, no. 1 (October 2021): 50–56. https://doi.org/10.1016/j.ygyno.2021.07.026.
    Full Text Link to Item
  - Albright, Benjamin B., Fumiko Chino, Junzo P. Chino, Laura J. Havrilesky, Emeline M. Aviki, and Haley A. Moss. “Associations of Insurance Churn and Catastrophic Health Expenditures With Implementation of the Affordable Care Act Among Nonelderly Patients With Cancer in the United States.” Jama Netw Open 4, no. 9 (September 1, 2021): e2124280. https://doi.org/10.1001/jamanetworkopen.2021.24280.
    Full Text Link to Item
  - Albright, Benjamin B., Karen A. Monuszko, Samantha J. Kaplan, Brittany A. Davidson, Haley A. Moss, Allan B. Huang, Alexander Melamed, Jason D. Wright, Laura J. Havrilesky, and Rebecca A. Previs. “Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis.” Am J Obstet Gynecol 225, no. 3 (September 2021): 237.e1-237.e24. https://doi.org/10.1016/j.ajog.2021.04.254.
    Full Text Link to Item
  - Albright, Benjamin B., Fumiko Chino, Junzo P. Chino, Laura J. Havrilesky, Emeline M. Aviki, and Haley A. Moss. “Medicaid Expansion Reduced Uninsured Surgical Hospitalizations And Associated Catastrophic Financial Burden.” Health Aff (Millwood) 40, no. 8 (August 2021): 1294–1303. https://doi.org/10.1377/hlthaff.2020.02496.
    Full Text Link to Item
  - Havrilesky, Laura J., Amelia L. Scott, Brittany A. Davidson, Angeles Alvarez Secord, Jui-Chen Yang, F Reed Johnson, Juan Marcos Gonzalez, and Shelby D. Reed. “The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.” Gynecol Oncol 162, no. 2 (August 2021): 440–46. https://doi.org/10.1016/j.ygyno.2021.05.022.
    Full Text Link to Item
  - Monuszko, Karen A., Benjamin Albright, Mary Katherine Montes De Oca, Nguyen Thao Thi Nguyen, Laura J. Havrilesky, and Brittany A. Davidson. “Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients.” Gynecol Oncol Rep 37 (August 2021): 100853. https://doi.org/10.1016/j.gore.2021.100853.
    Full Text Link to Item
  - Ryan, Emma S., Laura J. Havrilesky, Julia R. Salinaro, and Brittany A. Davidson. “Cost-Effectiveness of Venous Thromboembolism Prophylaxis During Neoadjuvant Chemotherapy for Ovarian Cancer.” Jco Oncol Pract 17, no. 8 (August 2021): e1075–84. https://doi.org/10.1200/OP.20.00783.
    Full Text Link to Item
  - Davis, Richard C., Gloria Broadwater, Wen-Chi Foo, Claudia K. Jones, Laura J. Havrilesky, and Sarah M. Bean. “Evaluation of pelvic washing specimens in patients with endometrial cancer: Cytomorphological features, diagnostic agreement, and pathologist experience.” Cancer Cytopathol 129, no. 7 (July 2021): 517–25. https://doi.org/10.1002/cncy.22406.
    Full Text Link to Item
  - Gonzalez, Rafael, Kelli Kurtovic, Ashraf S. Habib, Emma S. Ryan, Jonathan Foote, Dipali Pandya, Gloria Broadwater, and Laura J. Havrilesky. “A quality improvement initiative to reduce venous thromboembolism on a gynecologic oncology service.” Gynecol Oncol 162, no. 1 (July 2021): 120–27. https://doi.org/10.1016/j.ygyno.2021.04.035.
    Full Text Link to Item
  - Chung, E. H., S. L. Lim, L. J. Havrilesky, A. Z. Steiner, and S. K. Dotters-Katz. “Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.” Ultrasound Obstet Gynecol 57, no. 6 (June 2021): 979–86. https://doi.org/10.1002/uog.22048.
    Full Text Link to Item
  - Watson, Catherine H., Allison M. Puechl, Stephanie Lim, Karen Monuszko, Tracy Truong, Laura J. Havrilesky, and Brittany A. Davidson. “Chemotherapy discontinuation processes in a gynecologic oncology population.” Gynecol Oncol 161, no. 2 (May 2021): 508–11. https://doi.org/10.1016/j.ygyno.2021.03.003.
    Full Text Link to Item
  - Albright, Benjamin B., Fumiko Chino, Junzo P. Chino, Laura J. Havrilesky, Emeline M. Aviki, and Haley A. Moss. “Association of Medicaid expansion with mortality from gynecologic cancers.” Am J Obstet Gynecol 224, no. 3 (March 2021): 323–25. https://doi.org/10.1016/j.ajog.2020.11.024.
    Full Text Link to Item
  - Spinosa, Daniel, Tatiana Acosta, Janice Wong, Kelli Kurtovic, Jennifer Mewshaw, Sarah Collins, Noah Kauff, Laura J. Havrilesky, Kyle C. Strickland, and Rebecca A. Previs. “Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative.” Gynecol Oncol 160, no. 1 (January 2021): 169–74. https://doi.org/10.1016/j.ygyno.2020.10.016.
    Full Text Link to Item
  - Watson, Catherine H., Gloria Broadwater, Janice Wong, Daniel Spinosa, Mary Katherine Montes de Oca, Michael Datto, Michelle Green, et al. “Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.” Target Oncol 16, no. 1 (January 2021): 109–18. https://doi.org/10.1007/s11523-020-00785-z.
    Full Text Link to Item
  - Watson, Catherine H., Laura J. Fish, Margaret Falkovic, Karen Monuszko, Amelia Lorenzo, Laura J. Havrilesky, Angeles Alvarez Secord, and Brittany A. Davidson. “Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population.” Obstet Gynecol 136, no. 6 (December 2020): 1145–53. https://doi.org/10.1097/AOG.0000000000004170.
    Full Text Link to Item
  - Lim, Stephanie L., Laura J. Havrilesky, Robert P. Heine, and Sarah Dotters-Katz. “The cost-effectiveness of ertapenem for the treatment of chorioamnionitis after cesarean delivery.” J Matern Fetal Neonatal Med 33, no. 24 (December 2020): 4096–4101. https://doi.org/10.1080/14767058.2019.1597042.
    Full Text Link to Item
  - Gonzalez, Rafael, Laura J. Havrilesky, Evan R. Myers, Angeles Alvarez Secord, Joseph A. Dottino, Andrew Berchuck, and Haley A. Moss. “Cost-effectiveness analysis comparing "PARP inhibitors-for-all" to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer.” Gynecol Oncol 159, no. 2 (November 2020): 483–90. https://doi.org/10.1016/j.ygyno.2020.08.003.
    Full Text Link to Item
  - Son, Ji, Laura M. Chambers, Caitlin Carr, Chad M. Michener, Meng Yao, Anna Beavis, Ting-Tai Yen, et al. “Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.” Int J Gynecol Cancer 30, no. 11 (November 2020): 1738–47. https://doi.org/10.1136/ijgc-2020-001454.
    Full Text Link to Item
  - Watson, Catherine H., Lindsay Soo, Brittany A. Davidson, Laura J. Havrilesky, Paula S. Lee, Leah J. McNally, Rebecca A. Previs, Angeles Alvarez Secord, Andrew Berchuck, and Noah D. Kauff. “Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices.” Int J Gynecol Cancer 30, no. 10 (October 2020): 1583–88. https://doi.org/10.1136/ijgc-2020-001536.
    Full Text Link to Item
  - Fader, Amanda N., Dana M. Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko Chambers, et al. “Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.” Clin Cancer Res 26, no. 15 (August 1, 2020): 3928–35. https://doi.org/10.1158/1078-0432.CCR-20-0953.
    Full Text Link to Item
  - Lim, Stephanie L., Jui-Chen Yang, Jessie Ehrisman, Laura J. Havrilesky, and Shelby D. Reed. “Are Videos or Text Better for Describing Attributes in Stated-Preference Surveys?” Patient 13, no. 4 (August 2020): 401–8. https://doi.org/10.1007/s40271-020-00416-9.
    Full Text Link to Item
  - Salinaro, Julia Rose, Kourtnie McQuillen, Megan Stemple, Robert Boccaccio, Jessie Ehrisman, Amelia M. Lorenzo, Laura Havrilesky, et al. “Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.” Int J Gynecol Cancer 30, no. 4 (April 2020): 491–97. https://doi.org/10.1136/ijgc-2019-000980.
    Full Text Link to Item
  - Beavis, Anna L., Ting-Tai Yen, Rebecca L. Stone, Stephanie L. Wethington, Caitlin Carr, Ji Son, Laura Chambers, et al. “Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?” Gynecol Oncol 156, no. 3 (March 2020): 568–74. https://doi.org/10.1016/j.ygyno.2019.12.028.
    Full Text Link to Item
  - Bixel, K., M. Vetter, B. Davidson, A. Berchuck, D. Cohn, L. Copeland, J. M. Fowler, et al. “Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.” Gynecol Oncol 156, no. 3 (March 2020): 530–34. https://doi.org/10.1016/j.ygyno.2019.12.016.
    Full Text Link to Item
  - Havrilesky, Laura J., Stephanie Lim, Jessie A. Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui-Chen Yang, F Reed Johnson, Juan Marcos Gonzalez, and Shelby D. Reed. “Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.” Gynecol Oncol 156, no. 3 (March 2020): 561–67. https://doi.org/10.1016/j.ygyno.2020.01.026.
    Full Text Link to Item
  - Liang, Margaret I., Emeline M. Aviki, Jason D. Wright, Laura J. Havrilesky, Leslie R. Boyd, Haley A. Moss, Elizabeth L. Jewell, et al. “Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.” Gynecol Oncol 156, no. 3 (March 2020): 701–9. https://doi.org/10.1016/j.ygyno.2019.12.036.
    Full Text Link to Item
  - Williams, Logan K., Jeremy M. Weber, Carl Pieper, Amelia Lorenzo, Haley Moss, and Laura J. Havrilesky. “Lidocaine-Prilocaine Cream Compared With Injected Lidocaine for Vulvar Biopsy: A Randomized Controlled Trial.” Obstet Gynecol 135, no. 2 (February 2020): 311–18. https://doi.org/10.1097/AOG.0000000000003660.
    Full Text Link to Item
  - Chodavadia, Parth A., Corbin D. Jacobs, Frances Wang, Laura J. Havrilesky, Junzo P. Chino, and Gita Suneja. “Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data.” Gynecol Oncol 156, no. 1 (January 2020): 154–61. https://doi.org/10.1016/j.ygyno.2019.09.017.
    Full Text Link to Item
  - Hopkins, Maeve K., Lorraine Dugoff, Celeste Durnwald, Laura J. Havrilesky, and Sarah Dotters-Katz. “Cell-free DNA for Down syndrome screening in obese women: Is it a cost-effective strategy?” Prenat Diagn 40, no. 2 (January 2020): 173–78. https://doi.org/10.1002/pd.5605.
    Full Text Link to Item
  - VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.
    Full Text Open Access Copy Link to Item
  - Havrilesky, Laura J., Jui-Chen Yang, Paula S. Lee, Angeles Alvarez Secord, Jessie A. Ehrisman, Brittany Davidson, Andrew Berchuck, Kathleen M. Darcy, G Larry Maxwell, and Shelby D. Reed. “Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.” Cancer 125, no. 24 (December 15, 2019): 4399–4406. https://doi.org/10.1002/cncr.32447.
    Full Text Link to Item
  - Havrilesky, L. J., J. C. Yang, P. S. Lee, A. A. Secord, J. A. Ehrisman, B. Davidson, A. Berchuck, K. M. Darcy, G. L. Maxwell, and S. D. Reed. “Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer.” Obstetrical and Gynecological Survey 74, no. 12 (December 1, 2019): 718–19. https://doi.org/10.1097/OGX.0000000000000743.
    Full Text
  - Moss, Haley A., Laura J. Havrilesky, Frances F. Wang, Mihaela V. Georgieva, Laura H. Hendrix, and Michaela A. Dinan. “Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.” J Oncol Pract 15, no. 12 (December 2019): e1018–27. https://doi.org/10.1200/JOP.19.00026.
    Full Text Link to Item
  - Puechl, Allison M., Fumiko Chino, Laura J. Havrilesky, Brittany A. Davidson, and Junzo P. Chino. “Place of death by region and urbanization among gynecologic cancer patients: 2006-2016.” Gynecol Oncol 155, no. 1 (October 2019): 98–104. https://doi.org/10.1016/j.ygyno.2019.07.013.
    Full Text Link to Item
  - Lim, Stephanie L., Allison M. Puechl, Gloria Broadwater, Jessie A. Ehrisman, Amelia Lorenzo, Jonathan Foote, Brittany A. Davidson, Junzo Chino, and Laura J. Havrilesky. “Gender variation in Medicare utilization and payments in gynecologic oncology.” Gynecol Oncol 154, no. 3 (September 2019): 602–7. https://doi.org/10.1016/j.ygyno.2019.06.007.
    Full Text Link to Item
  - Gaillard, Stéphanie L., Kaitlyn J. Andreano, Laurie M. Gay, Meghan Steiner, Matthew S. Jorgensen, Brittany Anne Davidson, Laura J. Havrilesky, et al. “Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.” Gynecol Oncol 154, no. 1 (July 2019): 199–206. https://doi.org/10.1016/j.ygyno.2019.04.010.
    Full Text Link to Item
  - Schwartz, Amanda Rae, Stephanie Lim, Gloria Broadwater, Lauren Cobb, Fidel Valea, Julie Marosky Thacker, Ashraf Habib, and Laura Havrilesky. “Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service.” Int J Gynecol Cancer 29, no. 5 (June 2019): 935–43. https://doi.org/10.1136/ijgc-2018-000131.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Michael McCollum, Brittany A. Davidson, Gloria Broadwater, Robert Squatrito, Laura J. Havrilesky, Anne C. Gabel, et al. “Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.” Gynecol Oncol 153, no. 3 (June 2019): 555–61. https://doi.org/10.1016/j.ygyno.2019.03.246.
    Full Text Link to Item
  - Veade, Ashley E., Jonathan Foote, Jessie Ehrisman, Gloria Broadwater, Brittany A. Davidson, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, and Laura J. Havrilesky. “Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.” World J Surg Oncol 17, no. 1 (May 10, 2019): 80. https://doi.org/10.1186/s12957-019-1620-x.
    Full Text Link to Item
  - Arquiette, Jaclyn M., Haley A. Moss, Tracy Truong, Carl F. Pieper, and Laura J. Havrilesky. “Impact of a documentation intervention on health-assessment metrics on an inpatient gynecologic oncology service.” Gynecol Oncol 153, no. 2 (May 2019): 385–90. https://doi.org/10.1016/j.ygyno.2019.02.009.
    Full Text Link to Item
  - Jacobs, Corbin D., David J. Carpenter, Julian C. Hong, Laura J. Havrilesky, Julie A. Sosa, and Junzo P. Chino. “Radiation Records in the National Cancer Database: Variations in Coding and/or Practice Can Significantly Alter Survival Results.” Jco Clin Cancer Inform 3 (May 2019): 1–9. https://doi.org/10.1200/CCI.18.00118.
    Full Text Link to Item
  - Lim, Stephanie L., Laura J. Havrilesky, Ashraf S. Habib, and Angeles Alvarez Secord. “Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.” Gynecol Oncol 153, no. 2 (May 2019): 376–80. https://doi.org/10.1016/j.ygyno.2019.01.025.
    Full Text Link to Item
  - Watson, Catherine H., Micael Lopez-Acevedo, Gloria Broadwater, Amy H. Kim, Jessie Ehrisman, Brittany A. Davidson, Paula S. Lee, Fidel Valea, Andrew Berchuck, and Laura J. Havrilesky. “A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.” Gynecol Oncol 153, no. 2 (May 2019): 399–404. https://doi.org/10.1016/j.ygyno.2019.02.021.
    Full Text Link to Item
  - Dottino, Joseph A., Haley A. Moss, Karen H. Lu, Angeles A. Secord, and Laura J. Havrilesky. “U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis.” Obstet Gynecol 133, no. 4 (April 2019): 795–802. https://doi.org/10.1097/AOG.0000000000003171.
    Full Text Link to Item
  - Berger, Miles, Deborah Oyeyemi, Mobolaji O. Olurinde, Heather E. Whitson, Kent J. Weinhold, Marty G. Woldorff, Lewis A. Lipsitz, et al. “The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.” J Am Geriatr Soc 67, no. 4 (April 2019): 794–98. https://doi.org/10.1111/jgs.15770.
    Full Text Open Access Copy Link to Item
  - “Impact of a Documentation Intervention on Health-Assessment Metrics on an Inpatient Gynecologic Oncology Service [24A]: Correction.” Obstet Gynecol 133, no. 4 (April 2019): 834. https://doi.org/10.1097/AOG.0000000000003248.
    Full Text Link to Item
  - Foote, Jonathan R., Angeles Alvarez Secord, Margaret I. Liang, Jessie A. Ehrisman, David E. Cohn, Elizabeth Jewell, and Laura J. Havrilesky. “Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancer.” Gynecol Oncol 152, no. 3 (March 2019): 445–51. https://doi.org/10.1016/j.ygyno.2018.11.028.
    Full Text Link to Item
  - Havrilesky, Laura, and Jose Alejandro Rauh-Hain. “Health Services Research: Not just retrospective chart reviews.” Gynecol Oncol 152, no. 3 (March 2019): 437–38. https://doi.org/10.1016/j.ygyno.2019.01.028.
    Full Text Link to Item
  - Hopkins, Maeve K., Chad A. Grotegut, Geeta K. Swamy, Evan R. Myers, and Laura J. Havrilesky. “Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis.” Am J Perinatol 36, no. 4 (March 2019): 399–405. https://doi.org/10.1055/s-0038-1668591.
    Full Text Link to Item
  - Davidson, Brittany A., Jessie Ehrisman, Shelby D. Reed, Jui-Chen Yang, Adam Buchanan, and Laura J. Havrilesky. “Preferences of women with epithelial ovarian cancer for aspects of genetic testing.” Gynecol Oncol Res Pract 6 (2019): 1. https://doi.org/10.1186/s40661-019-0066-8.
    Full Text Link to Item
  - Spiegel, Daphna Y., Fumiko Chino, Haley Moss, Laura J. Havrilesky, and Junzo P. Chino. “Changes in insurance coverage for cancer patients receiving brachytherapy before and after enactment of the Affordable Care Act.” Brachytherapy 18, no. 1 (2019): 115–21. https://doi.org/10.1016/j.brachy.2018.08.017.
    Full Text Link to Item
  - Lim, Stephanie L., Haley A. Moss, Angeles Alvarez Secord, Paula S. Lee, Laura J. Havrilesky, and Brittany A. Davidson. “Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis.” Gynecol Oncol 151, no. 3 (December 2018): 506–12. https://doi.org/10.1016/j.ygyno.2018.09.020.
    Full Text Link to Item
  - Salinaro, Julia R., Allison M. Puechl, Laura J. Havrilesky, and Brittany A. Davidson. “Gender trends in gynecologic oncology authorship: Implications for the critical evaluation of gender distribution in academic rank and leadership positions.” Gynecol Oncol 151, no. 3 (December 2018): 542–46. https://doi.org/10.1016/j.ygyno.2018.10.009.
    Full Text Link to Item
  - Fader, Amanda N., Dana M. Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, et al. “Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.” J Clin Oncol 36, no. 20 (July 10, 2018): 2044–51. https://doi.org/10.1200/JCO.2017.76.5966.
    Full Text Link to Item
  - Havrilesky, Laura. “Measuring the Health Benefits of the Affordable Care Act for Young Women.” Obstet Gynecol 131, no. 6 (June 2018): 964–65. https://doi.org/10.1097/AOG.0000000000002651.
    Full Text Link to Item
  - Davidson, Brittany A., Jessie Ehrisman, Sara Abbott, Zach Harmon, Angeles A. Secord, Andrew Berchuck, Paula S. Lee, et al. “Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer.” Int J Gynecol Pathol 37, no. 3 (May 2018): 252–55. https://doi.org/10.1097/PGP.0000000000000418.
    Full Text Link to Item
  - Ko, Emily M., Laura J. Havrilesky, Ronald D. Alvarez, Oliver Zivanovic, Leslie R. Boyd, Elizabeth L. Jewell, Patrick F. Timmins, et al. “Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP).” Gynecol Oncol 149, no. 2 (May 2018): 232–40. https://doi.org/10.1016/j.ygyno.2018.02.010.
    Full Text Link to Item
  - Wright, Jason D., Laura J. Havrilesky, David E. Cohn, Yongmei Huang, Jill Rathbun, Laurel W. Rice, Carol L. Brown, Ronald D. Alvarez, and Emily M. Ko. “Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model.” Gynecol Oncol 149, no. 2 (May 2018): 241–47. https://doi.org/10.1016/j.ygyno.2018.02.011.
    Full Text Link to Item
  - Moss, Haley A., Goli Samimi, Laura J. Havrilesky, Mark E. Sherman, and Evan R. Myers. “Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.” Genet Epidemiol 42, no. 1 (February 2018): 117–22. https://doi.org/10.1002/gepi.22095.
    Full Text Link to Item
  - Foote, Jonathan, Micael Lopez-Acevedo, Gregory Samsa, Paula S. Lee, Arif H. Kamal, Angeles Alvarez Secord, and Laura J. Havrilesky. “Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals.” Int J Gynecol Cancer 28, no. 2 (February 2018): 302–7. https://doi.org/10.1097/IGC.0000000000001182.
    Full Text Link to Item
  - Moss, Haley A., Andrew Berchuck, Megan L. Neely, Evan R. Myers, and Laura J. Havrilesky. “Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).” Jama Oncol 4, no. 2 (February 1, 2018): 190–95. https://doi.org/10.1001/jamaoncol.2017.4211.
    Full Text Link to Item
  - Moss, Haley A., Laura J. Havrilesky, S Yousuf Zafar, Gita Suneja, and Junzo Chino. “Trends in Insurance Status Among Patients Diagnosed With Cancer Before and After Implementation of the Affordable Care Act.” J Oncol Pract 14, no. 2 (February 2018): e92–102. https://doi.org/10.1200/JOP.2017.027102.
    Full Text Link to Item
  - Williams, Grant R. “Geriatric Assessment: Precision Medicine for Older Adults With Cancer.” Journal of Oncology Practice 14, no. 2 (February 2018): 97–98. https://doi.org/10.1200/jop.18.00010.
    Full Text
  - Billingsley, Caroline C., David E. Cohn, Aleia K. Crim, Quan Li, David M. O’Malley, and Laura J. Havrilesky. “Is it reasonable to administer pegfilgrastim on day 1 of a myelosuppressive chemotherapy regimen? A cost-utility analysis.” Cancer Treat Res Commun 14 (2018): 21–25. https://doi.org/10.1016/j.ctarc.2017.11.003.
    Full Text Link to Item
  - Hong, Julian C., Daphna Y. Spiegel, Laura J. Havrilesky, and Junzo P. Chino. “High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis.” Brachytherapy 17, no. 6 (2018): 906–11. https://doi.org/10.1016/j.brachy.2018.07.007.
    Full Text Link to Item
  - Moss, Haley A., and Laura J. Havrilesky. “The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care.” Gynecol Oncol 148, no. 1 (January 2018): 12–18. https://doi.org/10.1016/j.ygyno.2017.11.011.
    Full Text Link to Item
  - Berchuck, Andrew, Angeles Alvarez Secord, Haley A. Moss, and Laura J. Havrilesky. “Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?” J Clin Oncol 35, no. 36 (December 20, 2017): 3999–4002. https://doi.org/10.1200/JCO.2017.74.5752.
    Full Text Link to Item
  - Tanner, Edward, Allison Puechl, Kimberly Levinson, Laura J. Havrilesky, Abdulrahman Sinno, Angeles Alvarez Secord, Amanda N. Fader, and Paula S. Lee. “Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.” Gynecol Oncol 147, no. 3 (December 2017): 535–40. https://doi.org/10.1016/j.ygyno.2017.10.020.
    Full Text Link to Item
  - Foote, Jonathan, Angeles Alvarez Secord, Margaret Liang, David E. Cohn, Elizabeth Jewell, and Laura J. Havrilesky. “ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian Cancer.” Journal of Oncology Practice 13, no. 12 (December 2017): e1030–39. https://doi.org/10.1200/jop.2017.025106.
    Full Text
  - Hong, Julian C., Jonathan Foote, Gloria Broadwater, Julie A. Sosa, Stephanie Gaillard, Laura J. Havrilesky, and Junzo P. Chino. “Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?” Jco Clin Cancer Inform 1 (November 2017): 1–15. https://doi.org/10.1200/CCI.16.00072.
    Full Text Link to Item
  - Bateman, Nicholas W., Elizabeth A. Dubil, Guisong Wang, Brian L. Hood, Julie M. Oliver, Tracy A. Litzi, Glenn D. Gist, et al. “Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.” Cancer 123, no. 20 (October 15, 2017): 4004–12. https://doi.org/10.1002/cncr.30813.
    Full Text Link to Item
  - Phippen, N. T., A. A. Secord, S. Wolf, G. Samsa, B. Davidson, A. P. Abernethy, D. Cella, et al. “Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.” Gynecol Oncol 147, no. 1 (October 2017): 98–103. https://doi.org/10.1016/j.ygyno.2017.07.121.
    Full Text Link to Item
  - Gamble, Charlotte, Laura J. Havrilesky, Evan R. Myers, Junzo P. Chino, Scott Hollenbeck, Jennifer K. Plichta, P. Kelly Marcom, E. Shelley Hwang, Noah D. Kauff, and Rachel A. Greenup. “Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.” Ann Surg Oncol 24, no. 11 (October 2017): 3116–23. https://doi.org/10.1245/s10434-017-5995-z.
    Full Text Link to Item
  - Havrilesky, Laura J. “The costs of adding laparoscopy to the management of advanced stage epithelial ovarian cancer.” Gynecol Oncol 146, no. 3 (September 2017): 441–42. https://doi.org/10.1016/j.ygyno.2017.07.140.
    Full Text Link to Item
  - Moss, Haley A., Laura J. Havrilesky, and Junzo Chino. “Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.” Gynecol Oncol 146, no. 3 (September 2017): 457–64. https://doi.org/10.1016/j.ygyno.2017.06.012.
    Full Text Link to Item
  - Dilley, Sarah E., Laura J. Havrilesky, Jamie Bakkum-Gamez, David E. Cohn, J. Michael Straughn, Aaron B. Caughey, and Maria I. Rodriguez. “Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.” Gynecol Oncol 146, no. 2 (August 2017): 373–79. https://doi.org/10.1016/j.ygyno.2017.05.034.
    Full Text Link to Item
  - Havrilesky, Laura J., Haley A. Moss, Junzo Chino, Evan R. Myers, and Noah D. Kauff. “Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.” Gynecol Oncol 145, no. 3 (June 2017): 549–54. https://doi.org/10.1016/j.ygyno.2017.03.025.
    Full Text Link to Item
  - Wenzel, L., D. Mukamel, K. Osann, L. Havrilesky, L. Sparks, J. Lipscomb, A. A. Wright, et al. “Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.” Contemp Clin Trials 57 (June 2017): 29–36. https://doi.org/10.1016/j.cct.2017.03.006.
    Full Text Link to Item
  - Berchuck, Andrew, Laura J. Havrilesky, and Noah D. Kauff. “Is There a Role for Ovarian Cancer Screening in High-Risk Women?” J Clin Oncol 35, no. 13 (May 1, 2017): 1384–86. https://doi.org/10.1200/JCO.2016.72.0045.
    Full Text Link to Item
  - Hong, Julian C., Jonathan Foote, Gloria Broadwater, Stéphanie Gaillard, Laura J. Havrilesky, and Junzo P. Chino. “Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.” Int J Gynecol Cancer 27, no. 4 (May 2017): 720–29. https://doi.org/10.1097/IGC.0000000000000926.
    Full Text Link to Item
  - Natesan, Divya, Julian C. Hong, Jonathan Foote, Julie A. Sosa, Laura Havrilesky, and Junzo Chino. “Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.” Int J Gynecol Cancer 27, no. 4 (May 2017): 794–804. https://doi.org/10.1097/IGC.0000000000000938.
    Full Text Link to Item
  - Cohn, David E., Emily Ko, Larissa A. Meyer, Jason D. Wright, Sarah M. Temkin, Jonathan Foote, Nathaniel L. Jones, and Laura J. Havrilesky. “The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations.” Gynecol Oncol 145, no. 1 (April 2017): 185–91. https://doi.org/10.1016/j.ygyno.2017.02.024.
    Full Text Link to Item
  - Pierce, Stuart R., Jessica E. Stine, Paola A. Gehrig, Laura J. Havrilesky, Angeles A. Secord, John Nakayama, Anna C. Snavely, Dominic T. Moore, and Kenneth H. Kim. “Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.” Gynecol Oncol 144, no. 3 (March 2017): 531–35. https://doi.org/10.1016/j.ygyno.2016.12.024.
    Full Text Link to Item
  - Foote, Jonathan R., Micael Lopez-Acevedo, Adam H. Buchanan, Angeles Alvarez Secord, Paula S. Lee, Cynthia Fountain, Evan R. Myers, David E. Cohn, Shelby D. Reed, and Laura J. Havrilesky. “Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.” J Oncol Pract 13, no. 2 (February 2017): e120–29. https://doi.org/10.1200/JOP.2016.011866.
    Full Text Link to Item
  - Foote, Jonathan R., Stephanie Gaillard, Gloria Broadwater, Julie A. Sosa, Brittany Davidson, Mohamed A. Adam, Angeles Alvarez Secord, Monica B. Jones, Junzo Chino, and Laura J. Havrilesky. “Disparities in the surgical staging of high-grade endometrial cancer in the United States.” Gynecol Oncol Res Pract 4 (2017): 1. https://doi.org/10.1186/s40661-016-0036-3.
    Full Text Open Access Copy Link to Item
  - Fountain, Cynthia R., and Laura J. Havrilesky. “Promoting Same-Day Discharge for Gynecologic Oncology Patients in Minimally Invasive Hysterectomy.” J Minim Invasive Gynecol 24, no. 6 (2017): 932–39. https://doi.org/10.1016/j.jmig.2017.05.005.
    Full Text Link to Item
  - Lee, Paula S., Samantha Kempner, Michael Miller, Jennifer Dominguez, Chad Grotegut, Jessie Ehrisman, Rebecca Previs, et al. “Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.” Gynecol Oncol Res Pract 4 (2017): 11. https://doi.org/10.1186/s40661-017-0049-6.
    Full Text Open Access Copy Link to Item
  - Miller, Caela R., Nicole P. Chappell, Caitlin Sledge, Charles A. Leath, Neil T. Phippen, Laura J. Havrilesky, and Jason C. Barnett. “Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?” Gynecol Oncol 144, no. 1 (January 2017): 125–29. https://doi.org/10.1016/j.ygyno.2016.10.038.
    Full Text Link to Item
  - Natesan, Divya, Matthew Susko, Laura Havrilesky, and Junzo Chino. “Definitive Chemoradiotherapy for Vulvar Cancer.” Int J Gynecol Cancer 26, no. 9 (November 2016): 1699–1705. https://doi.org/10.1097/IGC.0000000000000811.
    Full Text Link to Item
  - Dottino, Joseph A., Vic Hasselblad, Angeles Alvarez Secord, Evan R. Myers, Junzo Chino, and Laura J. Havrilesky. “Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.” Obstet Gynecol 128, no. 4 (October 2016): 747–53. https://doi.org/10.1097/AOG.0000000000001616.
    Full Text Link to Item
  - Morgan, Robert J., Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-May Chen, Larry Copeland, et al. “Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 14, no. 9 (September 2016): 1134–63. https://doi.org/10.6004/jnccn.2016.0122.
    Full Text Link to Item
  - Ehrisman, Jessie, Angeles Alvarez Secord, Andrew Berchuck, Paula S. Lee, Nicola Di Santo, Micael Lopez-Acevedo, Gloria Broadwater, Fidel A. Valea, and Laura J. Havrilesky. “Performance of sentinel lymph node biopsy in high-risk endometrial cancer.” Gynecol Oncol Rep 17 (August 2016): 69–71. https://doi.org/10.1016/j.gore.2016.04.002.
    Full Text Link to Item
  - Davidson, Brittany A., Jonathan Foote, Leslie H. Clark, Gloria Broadwater, Jessie Ehrisman, Paola Gehrig, Whitney Graybill, Angeles Alvarez Secord, and Laura J. Havrilesky. “Tumor grade and chemotherapy response in endometrioid endometrial cancer.” Gynecol Oncol Rep 17 (August 2016): 3–6. https://doi.org/10.1016/j.gore.2016.04.006.
    Full Text Link to Item
  - Wallbillich, J. J., B. Forde, L. J. Havrilesky, and D. E. Cohn. “A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy.” Gynecol Oncol 142, no. 1 (July 2016): 144–49. https://doi.org/10.1016/j.ygyno.2016.04.024.
    Full Text Link to Item
  - Phippen, Neil T., Laura J. Havrilesky, Jason C. Barnett, Chad A. Hamilton, Michael P. Stany, and William J. Lowery. “Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?” Int J Gynecol Cancer 26, no. 5 (June 2016): 944–50. https://doi.org/10.1097/IGC.0000000000000705.
    Full Text Link to Item
  - Secord, Angeles Alvarez, and Laura J. Havrilesky. “Is Intraperitoneal Chemotherapy Dead?” Obstet Gynecol 127, no. 6 (June 2016): 983–84. https://doi.org/10.1097/AOG.0000000000001461.
    Full Text Link to Item
  - Bush, Stephen H., Sharon Tollin, Douglas C. Marchion, Yin Xiong, Forough Abbasi, Ingrid J. Ramirez, Nadim Bou Zgheib, et al. “Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.” Mol Clin Oncol 4, no. 3 (March 2016): 399–404. https://doi.org/10.3892/mco.2016.725.
    Full Text Link to Item
  - Davidson, Brittany A., Jonathan Foote, Stacey L. Brower, Chunqiao Tian, Laura J. Havrilesky, and Angeles Alvarez Secord. “Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis.” Gynecol Oncol Res Pract 3 (2016): 13. https://doi.org/10.1186/s40661-016-0032-7.
    Full Text Open Access Copy Link to Item
  - Merk, Brittany A., Laura J. Havrilesky, Jessie A. Ehrisman, Gloria Broadwater, and Ashraf S. Habib. “Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.” Curr Med Res Opin 32, no. 3 (2016): 453–58. https://doi.org/10.1185/03007995.2015.1123146.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Vic Hasselblad, Vivian E. Von Gruenigen, Paola A. Gehrig, Susan C. Modesitt, Victoria Bae-Jump, and Laura J. Havrilesky. “Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.” Gynecol Oncol 140, no. 1 (January 2016): 184–90. https://doi.org/10.1016/j.ygyno.2015.10.020.
    Full Text Link to Item
  - Hess, Lisa M., Helen Q. Huang, Alexandra L. Hanlon, William R. Robinson, Rhonda Johnson, Setsuko K. Chambers, Robert S. Mannel, et al. “Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.” Gynecol Oncol 139, no. 3 (December 2015): 541–45. https://doi.org/10.1016/j.ygyno.2015.10.003.
    Full Text Link to Item
  - Dickson, Elizabeth L., Rachel Isaksson Vogel, Paola A. Gehrig, Stuart Pierce, Laura Havrilesky, Angeles Alvarez Secord, Joseph Dottino, Amanda N. Fader, Stephanie Ricci, and Melissa A. Geller. “A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.” Gynecol Oncol 139, no. 2 (November 2015): 275–82. https://doi.org/10.1016/j.ygyno.2015.09.002.
    Full Text Link to Item
  - Myers, Evan R., Patricia Moorman, Jennifer M. Gierisch, Laura J. Havrilesky, Lars J. Grimm, Sujata Ghate, Brittany Davidson, et al. “Benefits and Harms of Breast Cancer Screening: A Systematic Review.” Jama 314, no. 15 (October 20, 2015): 1615–34. https://doi.org/10.1001/jama.2015.13183.
    Full Text Link to Item
  - Cohn, David E., Laura J. Havrilesky, Kathryn Osann, Joseph Lipscomb, Susie Hsieh, Joan L. Walker, Alexi A. Wright, et al. “Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice.” Gynecol Oncol 138, no. 3 (September 2015): 712–16. https://doi.org/10.1016/j.ygyno.2015.07.014.
    Full Text Link to Item
  - Dottino, Joseph A., William A. Cliby, Evan R. Myers, Robert E. Bristow, and Laura J. Havrilesky. “Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.” Gynecol Oncol 138, no. 3 (September 2015): 694–99. https://doi.org/10.1016/j.ygyno.2015.06.013.
    Full Text Link to Item
  - Neff, Robert, Laura J. Havrilesky, Junzo Chino, David M. O’Malley, and David E. Cohn. “Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome.” Gynecol Oncol 138, no. 3 (September 2015): 597–602. https://doi.org/10.1016/j.ygyno.2015.07.002.
    Full Text Link to Item
  - Zhang, Chelsea, Dario Roque, Jessie A. Ehrisman, Nicola DiSanto, Gloria Broadwater, Kemi M. Doll, Paola A. Gehrig, Angeles Alvarez Secord, and Laura J. Havrilesky. “Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer.” Gynecol Oncol Rep 13 (August 2015): 49–52. https://doi.org/10.1016/j.gore.2015.06.004.
    Full Text Link to Item
  - Brooks, Sandra E., Randy L. Carter, Steven C. Plaxe, Karen M. Basen-Engquist, Michael Rodriguez, James Kauderer, Joan L. Walker, et al. “Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.” Gynecol Oncol 138, no. 1 (July 2015): 101–8. https://doi.org/10.1016/j.ygyno.2015.04.033.
    Full Text Link to Item
  - Kushnir, C. L., A. M. Angarita, L. J. Havrilesky, S. Thompson, D. Spahlinger, A. K. Sinno, E. J. Tanner, et al. “Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD).” Gynecol Oncol 137, no. 3 (June 2015): 503–7. https://doi.org/10.1016/j.ygyno.2015.02.020.
    Full Text Link to Item
  - Phippen, N. T., L. J. Havrilesky, J. C. Barnett, C. A. Hamilton, M. Stany, and W. J. Lowery. “Abstract 10: Does routine post-treatment PET/CT add value to the care of women with locally advanced cervical cancer?” Gynecologic Oncology 137, no. 3 (June 2015): 594–95. https://doi.org/10.1016/j.ygyno.2015.03.027.
    Full Text
  - Secord, Angeles A., Robert L. Coleman, Laura J. Havrilesky, Amy P. Abernethy, Gregory P. Samsa, and David Cella. “Patient-reported outcomes as end points and outcome indicators in solid tumours.” Nat Rev Clin Oncol 12, no. 6 (June 2015): 358–70. https://doi.org/10.1038/nrclinonc.2015.29.
    Full Text Link to Item
  - Havrilesky, L. J., M. Dinan, G. P. Sfakianos, L. H. Curtis, J. C. Barnett, T. Van Gorp, and E. R. Myers. “Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.” Obstetrical and Gynecological Survey 70, no. 4 (April 22, 2015): 253–55. https://doi.org/10.1097/01.ogx.0000464937.42384.2d.
    Full Text
  - Havrilesky, Laura J., Maureen Reiner, Phuong Khanh Morrow, Holly Watson, and Jeffrey Crawford. “A review of relative dose intensity and survival in patients with metastatic solid tumors.” Crit Rev Oncol Hematol 93, no. 3 (March 2015): 203–10. https://doi.org/10.1016/j.critrevonc.2014.10.006.
    Full Text Link to Item
  - Cohn, David E., Jason C. Barnett, Lari Wenzel, Bradley J. Monk, Robert A. Burger, J Michael Straughn, Evan R. Myers, and Laura J. Havrilesky. “A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer.” Gynecol Oncol 136, no. 2 (February 2015): 293–99. https://doi.org/10.1016/j.ygyno.2014.10.020.
    Full Text Link to Item
  - McCann, Georgia A., David E. Cohn, Elizabeth L. Jewell, and Laura J. Havrilesky. “Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.” Gynecol Oncol 136, no. 2 (February 2015): 300–304. https://doi.org/10.1016/j.ygyno.2014.11.079.
    Full Text Link to Item
  - Phippen, Neil T., Charles A. Leath, Laura J. Havrilesky, and Jason C. Barnett. “Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?” Gynecol Oncol 136, no. 1 (January 2015): 43–47. https://doi.org/10.1016/j.ygyno.2014.11.003.
    Full Text Link to Item
  - Havrilesky, Laura J., Michaela Dinan, Gregory P. Sfakianos, Lesley H. Curtis, Jason C. Barnett, Toon Van Gorp, and Evan R. Myers. “Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.” J Natl Cancer Inst 107, no. 1 (January 2015): 322. https://doi.org/10.1093/jnci/dju322.
    Full Text Link to Item
  - Turner, Taylor B., Ashraf S. Habib, Gloria Broadwater, Fidel A. Valea, Nicole D. Fleming, Jessie A. Ehrisman, Nicola Di Santo, and Laura J. Havrilesky. “Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging.” J Minim Invasive Gynecol 22, no. 6 (2015): 1004–10. https://doi.org/10.1016/j.jmig.2015.05.003.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles Alvarez Secord, Jessie A. Ehrisman, Andrew Berchuck, Fidel A. Valea, Paula S. Lee, Stephanie L. Gaillard, et al. “Patient preferences in advanced or recurrent ovarian cancer.” Cancer 120, no. 23 (December 1, 2014): 3651–59. https://doi.org/10.1002/cncr.28940.
    Full Text Link to Item
  - Kokosis, G., R. Schmitz, A. A. Secord, L. J. Havrilesky, A. Berchuck, C. R. Mantyh, and D. Erdmann. “A modified bipedicle VRAM flap for simultaneous reconstruction of a perineal and posterior vaginal defect.” Gynakologe 47, no. 10 (October 14, 2014): 784–87. https://doi.org/10.1007/s00129-014-3448-3.
    Full Text
  - Zhang, Chelsea, Laura J. Havrilesky, Gloria Broadwater, Nicola Di Santo, Jessie A. Ehrisman, Paula S. Lee, Andrew Berchuck, et al. “Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.” Gynecol Oncol 133, no. 2 (May 2014): 211–15. https://doi.org/10.1016/j.ygyno.2014.02.025.
    Full Text Link to Item
  - Ko, Emily M., Paige Walter, Leslie Clark, Amanda Jackson, Jason Franasiak, Corey Bolac, Laura Havrilesky, et al. “The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.” Gynecol Oncol 133, no. 1 (April 2014): 28–32. https://doi.org/10.1016/j.ygyno.2014.01.032.
    Full Text Link to Item
  - Lewis, Lauren S., Patricia A. Convery, Corey S. Bolac, Fidel A. Valea, William J. Lowery, and Laura J. Havrilesky. “Cost of care using prophylactic negative pressure wound vacuum on closed laparotomy incisions.” Gynecol Oncol 132, no. 3 (March 2014): 684–89. https://doi.org/10.1016/j.ygyno.2014.01.014.
    Full Text Link to Item
  - Ko, Emily M., Paige Walter, Amanda Jackson, Leslie Clark, Jason Franasiak, Corey Bolac, Laura J. Havrilesky, et al. “Metformin is associated with improved survival in endometrial cancer.” Gynecol Oncol 132, no. 2 (February 2014): 438–42. https://doi.org/10.1016/j.ygyno.2013.11.021.
    Full Text Link to Item
  - Havrilesky, Laura J. “Palliative services enhance the quality and value of gynecologic cancer care.” Gynecol Oncol 132, no. 1 (January 2014): 1–2. https://doi.org/10.1016/j.ygyno.2013.12.035.
    Full Text Link to Item
  - Havrilesky, Laura J., and Cynthia Fountain. “Can we maximize both value and quality in gynecologic cancer care? A work in progress.” Am Soc Clin Oncol Educ Book, 2014, e268–75. https://doi.org/10.14694/EdBook_AM.2014.34.e268.
    Full Text Link to Item
  - Ricci, Stephanie, Robert L. Giuntoli, Eric Eisenhauer, Micael A. Lopez, Lauren Krill, Edward J. Tanner, Paola A. Gehrig, et al. “Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?” Gynecol Oncol 131, no. 3 (December 2013): 629–33. https://doi.org/10.1016/j.ygyno.2013.08.037.
    Full Text Link to Item
  - Moorman, Patricia G., Laura J. Havrilesky, Jennifer M. Gierisch, Remy R. Coeytaux, William J. Lowery, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.” J Clin Oncol 31, no. 33 (November 20, 2013): 4188–98. https://doi.org/10.1200/JCO.2013.48.9021.
    Full Text Link to Item
  - Gierisch, Jennifer M., Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.” Cancer Epidemiol Biomarkers Prev 22, no. 11 (November 2013): 1931–43. https://doi.org/10.1158/1055-9965.EPI-13-0298.
    Full Text Link to Item
  - Havrilesky, Laura J., Evan R. Myers, and Walter L. Thomas. “In reply.” Obstet Gynecol 122, no. 5 (November 2013): 1114. https://doi.org/10.1097/01.AOG.0000435077.65209.72.
    Full Text Link to Item
  - Barnett, Jason C., Angeles Alvarez Secord, David E. Cohn, Charles A. Leath, Evan R. Myers, and Laura J. Havrilesky. “Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer.” Cancer 119, no. 20 (October 15, 2013): 3653–61. https://doi.org/10.1002/cncr.28283.
    Full Text Link to Item
  - Morgan, Robert J., Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, et al. “Ovarian cancer, version 2.2013.” J Natl Compr Canc Netw 11, no. 10 (October 1, 2013): 1199–1209. https://doi.org/10.6004/jnccn.2013.0142.
    Full Text Link to Item
  - Havrilesky, Laura J., Junzo P. Chino, and Evan R. Myers. “How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis.” Gynecol Oncol 131, no. 1 (October 2013): 140–46. https://doi.org/10.1016/j.ygyno.2013.06.025.
    Full Text Link to Item
  - Lopez-Acevedo, Micael, William J. Lowery, Ashlei W. Lowery, Paula S. Lee, and Laura J. Havrilesky. “Palliative and hospice care in gynecologic cancer: a review.” Gynecol Oncol 131, no. 1 (October 2013): 215–21. https://doi.org/10.1016/j.ygyno.2013.06.012.
    Full Text Link to Item
  - Lowery, William J., Ashlei W. Lowery, Jason C. Barnett, Micael Lopez-Acevedo, Paula S. Lee, Angeles Alvarez Secord, and Laura Havrilesky. “Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer.” Gynecol Oncol 130, no. 3 (September 2013): 426–30. https://doi.org/10.1016/j.ygyno.2013.06.011.
    Full Text Link to Item
  - Tergas, Ana I., Laura J. Havrilesky, Amanda N. Fader, Saketh R. Guntupalli, Warner K. Huh, L Stewart Massad, and B. J. Rimel. “Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer.” Gynecol Oncol 130, no. 3 (September 2013): 421–25. https://doi.org/10.1016/j.ygyno.2013.05.037.
    Full Text Link to Item
  - Phippen, Neil T., Charles A. Leath, Caela R. Miller, William J. Lowery, Laura J. Havrilesky, and Jason C. Barnett. “Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer?” Gynecol Oncol 130, no. 2 (August 2013): 317–22. https://doi.org/10.1016/j.ygyno.2013.05.019.
    Full Text Link to Item
  - Peragallo Urrutia, Rachel, Remy R. Coeytaux, Amanda J. McBroom, Jennifer M. Gierisch, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.” Obstet Gynecol 122, no. 2 Pt 1 (August 2013): 380–89. https://doi.org/10.1097/AOG.0b013e3182994c43.
    Full Text Link to Item
  - Jewell, Elizabeth L., Michael Smrtka, Gloria Broadwater, Fidel Valea, Debra M. Davis, Kimberly C. Nolte, Renea Valea, Evan R. Myers, and Laura J. Havrilesky. “Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers.” Int J Gynecol Cancer 23, no. 6 (July 2013): 1158–66. https://doi.org/10.1097/IGC.0b013e318299e2a6.
    Full Text Link to Item
  - Lopez-Acevedo, Micael, Laura J. Havrilesky, Gloria Broadwater, Arif H. Kamal, Amy P. Abernethy, Andrew Berchuck, Angeles Alvarez Secord, James A. Tulsky, Fidel Valea, and Paula S. Lee. “Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.” Gynecol Oncol 130, no. 1 (July 2013): 156–61. https://doi.org/10.1016/j.ygyno.2013.04.010.
    Full Text Link to Item
  - Wenham, Robert M., James Lapolla, Hui-Yi Lin, Sachin M. Apte, Johnathan M. Lancaster, Patricia L. Judson, Jesus Gonzalez-Bosquet, Amber Herschberger, Laura J. Havrilesky, and Angeles Alvarez Secord. “A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.” Gynecol Oncol 130, no. 1 (July 2013): 19–24. https://doi.org/10.1016/j.ygyno.2013.04.049.
    Full Text Link to Item
  - Havrilesky, Laura J., Patricia G. Moorman, William J. Lowery, Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.” Obstet Gynecol 122, no. 1 (July 2013): 139–47. https://doi.org/10.1097/AOG.0b013e318291c235.
    Full Text Link to Item
  - Havrilesky, Laura J., Jennifer M. Gierisch, Patricia G. Moorman, Remy R. Coeytaux, Rachel Peragallo Urrutia, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use for the primary prevention of ovarian cancer.” Evid Rep Technol Assess (Full Rep), no. 212 (June 2013): 1–514.
    Link to Item
  - Secord, Angeles Alvarez, Jason Cory Barnett, Jonathan A. Ledermann, Bercedis L. Peterson, Evan R. Myers, and Laura J. Havrilesky. “Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.” Int J Gynecol Cancer 23, no. 5 (June 2013): 846–52. https://doi.org/10.1097/IGC.0b013e31829527bd.
    Full Text Link to Item
  - Bolac, Corey S., Amy H. Wallace, Gloria Broadwater, Laura J. Havrilesky, and Ashraf S. Habib. “The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer.” Anesth Analg 116, no. 5 (May 2013): 1041–47. https://doi.org/10.1213/ANE.0b013e318276cf58.
    Full Text Link to Item
  - Hanna, Rabbie K., Marek S. Poniewierski, Robin A. Laskey, Micael A. Lopez, Aaron Shafer, Linda Van Le, Jeffrey Crawford, et al. “Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer.” Gynecol Oncol 129, no. 1 (April 2013): 74–80. https://doi.org/10.1016/j.ygyno.2012.12.017.
    Full Text Link to Item
  - Alvarez, Ronald D., Heidi J. Gray, Patrick F. Timmins, Randall K. Gibb, Mitchell Edelson, Jeffrey M. Fowler, Laura J. Havrilesky, et al. “We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.” Gynecol Oncol 129, no. 1 (April 2013): 3–4. https://doi.org/10.1016/j.ygyno.2013.02.010.
    Full Text Link to Item
  - Kulasingam, Shalini L., Laura J. Havrilesky, Rahel Ghebre, and Evan R. Myers. “Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.” J Low Genit Tract Dis 17, no. 2 (April 2013): 193–202. https://doi.org/10.1097/LGT.0b013e3182616241.
    Full Text Link to Item
  - Havrilesky, Laura J., and Amy P. Abernethy. “Quality of life in ICON7: need for patients' perspectives.” Lancet Oncol 14, no. 3 (March 2013): 183–85. https://doi.org/10.1016/S1470-2045(12)70590-9.
    Full Text Link to Item
  - Hess, Lisa M., William E. Brady, Laura J. Havrilesky, David E. Cohn, Bradley J. Monk, Lari Wenzel, and David Cella. “Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study.” Gynecol Oncol 128, no. 2 (February 2013): 175–80. https://doi.org/10.1016/j.ygyno.2012.10.024.
    Full Text Link to Item
  - Peragallo Urrutia, R., R. R. Coeytaux, A. J. McBroom, J. M. Gierisch, L. J. Havrilesky, P. G. Moorman, W. J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.” Obstetrics and Gynecology 122, no. 2 Pt 1 (January 1, 2013): 380–89.
  - Secord, Angeles Alvarez, Melissa A. Geller, Gloria Broadwater, Robert Holloway, Kevin Shuler, Nhu-Y Dao, Paola A. Gehrig, David M. O’Malley, Neil Finkler, and Laura J. Havrilesky. “A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer.” Gynecol Oncol 128, no. 1 (January 2013): 65–70. https://doi.org/10.1016/j.ygyno.2012.10.010.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Marcus Q. Bernardini, Gloria Broadwater, Lisa A. Grace, Zhiqing Huang, Tsukasa Baba, Eiji Kondoh, Gregory Sfakianos, Laura J. Havrilesky, and Susan K. Murphy. “TP53 Status is Associated with Thrombospondin1 Expression In vitro.” Front Oncol 3 (2013): 269. https://doi.org/10.3389/fonc.2013.00269.
    Full Text Link to Item
  - Danesh, Kaveh, Rick Durrett, Laura J. Havrilesky, and Evan Myers. “A branching process model of ovarian cancer.” J Theor Biol 314 (December 7, 2012): 10–15. https://doi.org/10.1016/j.jtbi.2012.08.025.
    Full Text Link to Item
  - Lopez-Acevedo, Micael, Chelsea Zhang, Angeles Alvarez Secord, Paula S. Lee, Laura Jean Havrilesky, and Andrew Berchuck. “Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery.” Journal of Clinical Oncology 30, no. 34 (December 1, 2012). https://doi.org/10.1200/jco.2012.30.34_suppl.201.
    Full Text Link to Item
  - Zhang, C., A. A. Secord, P. S. Lee, L. J. Havrilesky, and A. Berchuck. “Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery.” J Clin Oncol 30, no. 34_suppl (December 2012): 201. https://doi.org/10.1200/jco.2012.30.34_suppl.201.
    Full Text Link to Item
  - Giugale, Lauren E., Nicola Di Santo, Mark E. Smolkin, Laura J. Havrilesky, and Susan C. Modesitt. “Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.” Gynecol Oncol 127, no. 2 (November 2012): 326–31. https://doi.org/10.1016/j.ygyno.2012.08.014.
    Full Text Link to Item
  - Morgan, Robert J., Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Mariana Castells, Lee-may Chen, Larry Copeland, et al. “Ovarian cancer, version 3.2012.” J Natl Compr Canc Netw 10, no. 11 (November 1, 2012): 1339–49. https://doi.org/10.6004/jnccn.2012.0140.
    Full Text Link to Item
  - Lowery, W. J., P. A. Gehrig, E. Ko, A. A. Secord, J. Chino, and L. J. Havrilesky. “Surgical staging for endometrial cancer in the elderly - Is there a role for lymphadenectomy?” Obstetrical and Gynecological Survey 67, no. 11 (November 1, 2012): 702–3. https://doi.org/10.1097/OGX.0b013e31827681f1.
    Full Text
  - Phippen, Neil T., Charles A. Leath, Junzo P. Chino, Elizabeth L. Jewell, Laura J. Havrilesky, and Jason C. Barnett. “Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.” Gynecol Oncol 127, no. 2 (November 2012): 267–72. https://doi.org/10.1016/j.ygyno.2012.08.002.
    Full Text Link to Item
  - Cantrell, Leigh A., Laura Havrilesky, Dominic T. Moore, David O’Malley, Margaret Liotta, Angeles Alvarez Secord, Christa I. Nagel, et al. “A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.” Gynecol Oncol 127, no. 1 (October 2012): 22–26. https://doi.org/10.1016/j.ygyno.2012.06.020.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Deanna K. Teoh, William T. Barry, Miao Yu, Gloria Broadwater, Laura J. Havrilesky, Paula S. Lee, Andrew Berchuck, Johnathan Lancaster, and Robert M. Wenham. “A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.” Clin Cancer Res 18, no. 19 (October 1, 2012): 5489–98. https://doi.org/10.1158/1078-0432.CCR-12-0507.
    Full Text Link to Item
  - Fader, Amanda Nickles, Leigh G. Seamon, Pedro F. Escobar, Heidi E. Frasure, Laura A. Havrilesky, Kristine M. Zanotti, Angeles Alvarez Secord, et al. “Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.” Gynecol Oncol 126, no. 2 (August 2012): 180–85. https://doi.org/10.1016/j.ygyno.2012.04.028.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Andrew Berchuck, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Fidel A. Valea, and Laura J. Havrilesky. “A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” Cancer 118, no. 13 (July 1, 2012): 3283–93. https://doi.org/10.1002/cncr.26610.
    Full Text Link to Item
  - Lowery, William J., Paola A. Gehrig, Emily Ko, Angeles Alvarez Secord, Junzo Chino, and Laura J. Havrilesky. “Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?” Gynecol Oncol 126, no. 1 (July 2012): 12–15. https://doi.org/10.1016/j.ygyno.2012.05.003.
    Full Text Link to Item
  - Havrilesky, Laura J., Craig F. Garfield, Jason C. Barnett, and David E. Cohn. “Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer.” Gynecol Oncol 125, no. 3 (June 2012): 631–34. https://doi.org/10.1016/j.ygyno.2012.03.028.
    Full Text Link to Item
  - Laskey, Robin A., Marek S. Poniewierski, Micael A. Lopez, Rabbie K. Hanna, Angeles Alvarez Secord, Paola A. Gehrig, Gary H. Lyman, and Laura J. Havrilesky. “Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.” Gynecol Oncol 125, no. 3 (June 2012): 625–30. https://doi.org/10.1016/j.ygyno.2012.03.015.
    Full Text Link to Item
  - Kulasingam, Shalini, and Laura Havrilesky. “Health economics of screening for gynaecological cancers.” Best Pract Res Clin Obstet Gynaecol 26, no. 2 (April 2012): 163–73. https://doi.org/10.1016/j.bpobgyn.2011.10.013.
    Full Text Link to Item
  - Chino, Junzo P., Ellen Jones, Andrew Berchuck, Angeles Alvarez Secord, and Laura J. Havrilesky. “The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer.” Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): 1872–79. https://doi.org/10.1016/j.ijrobp.2011.03.054.
    Full Text Link to Item
  - Berchuck, Andrew, Angeles Alvarez Secord, and Laura J. Havrilesky. “Minimally invasive surgery for endometrial cancer: the horse is already out of the barn.” J Clin Oncol 30, no. 7 (March 1, 2012): 681–82. https://doi.org/10.1200/JCO.2011.40.5506.
    Full Text Link to Item
  - Ramirez, Pedro T., Sarah Adams, John F. Boggess, William M. Burke, Michael M. Frumovitz, Ginger J. Gardner, Laura J. Havrilesky, et al. “Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.” Gynecol Oncol 124, no. 2 (February 2012): 180–84. https://doi.org/10.1016/j.ygyno.2011.11.006.
    Full Text Link to Item
  - Havrilesky, Laura J., Robin Pokrzywinski, Dennis Revicki, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Andrew Berchuck, Evan R. Myers, and Angeles Alvarez Secord. “Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer.” Cancer 118, no. 2 (January 15, 2012): 386–91. https://doi.org/10.1002/cncr.26199.
    Full Text Link to Item
  - Behera, Millie A., Creighton E. Likes, John P. Judd, Jason C. Barnett, Laura J. Havrilesky, and Jennifer M. Wu. “Cost analysis of abdominal, laparoscopic, and robotic-assisted myomectomies.” J Minim Invasive Gynecol 19, no. 1 (2012): 52–57. https://doi.org/10.1016/j.jmig.2011.09.007.
    Full Text Link to Item
  - Pokrzywinski, Robin, Angeles Alvarez Secord, Laura J. Havrilesky, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, and Dennis A. Revicki. “Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.” Gynecol Oncol 123, no. 3 (December 2011): 505–10. https://doi.org/10.1016/j.ygyno.2011.08.015.
    Full Text Link to Item
  - McElligott, Kara A., Laura J. Havrilesky, and Evan R. Myers. “Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: a cost comparison study.” Am J Obstet Gynecol 205, no. 5 (November 2011): 500.e1-500.e7. https://doi.org/10.1016/j.ajog.2011.07.012.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Kathleen M. Darcy, Alan Hutson, Zhiqing Huang, Paula S. Lee, Elizabeth L. Jewell, Laura J. Havrilesky, Maurie Markman, Franco Muggia, and Susan K. Murphy. “The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.” Gynecol Oncol 123, no. 2 (November 2011): 314–19. https://doi.org/10.1016/j.ygyno.2011.08.003.
    Full Text Link to Item
  - Convery, Patricia A., Leigh A. Cantrell, Nicola Di Santo, Gloria Broadwater, Susan C. Modesitt, Angeles Alvarez Secord, and Laura J. Havrilesky. “Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.” Gynecol Oncol 123, no. 1 (October 2011): 65–70. https://doi.org/10.1016/j.ygyno.2011.06.025.
    Full Text Link to Item
  - Teoh, Deanna, Andrew Berchuck, Angeles Alvarez Secord, Paula S. Lee, William J. Lowery, Gregory P. Sfakianos, Fidel A. Valea, Evan R. Myers, and Laura J. Havrilesky. “Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer.” Gynecol Oncol 122, no. 3 (September 2011): 467–72. https://doi.org/10.1016/j.ygyno.2011.06.014.
    Full Text Link to Item
  - Barnett, Jason C., Laura J. Havrilesky, Amy E. Bondurant, Nicole D. Fleming, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, and Fidel A. Valea. “Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer.” Am J Obstet Gynecol 205, no. 2 (August 2011): 143.e1-143.e6. https://doi.org/10.1016/j.ajog.2011.03.012.
    Full Text Link to Item
  - Jewell, Elizabeth L., Michael Smrtka, Gloria Broadwater, Fidel Valea, Debra M. Davis, Kimberly C. Nolte, Renea Valea, Evan R. Myers, Gregory Samsa, and Laura J. Havrilesky. “Utility scores and treatment preferences for clinical early-stage cervical cancer.” Value Health 14, no. 4 (June 2011): 582–86. https://doi.org/10.1016/j.jval.2010.11.017.
    Full Text Link to Item
  - Havrilesky, L. J., R. K. Hanna, M. S. Poniewierski, R. Laskey, A. A. Secord, P. A. Gehrig, M. A. Lopez, et al. “Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.” J Clin Oncol 29, no. 15_suppl (May 20, 2011): 5084.
    Link to Item
  - Havrilesky, Laura J., Gillian D. Sanders, Shalini Kulasingam, Junzo P. Chino, Andrew Berchuck, Jeffrey R. Marks, and Evan R. Myers. “Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.” Cancer 117, no. 3 (February 1, 2011): 545–53. https://doi.org/10.1002/cncr.25624.
    Full Text Link to Item
  - Fleming, Nicole D., Laura J. Havrilesky, Fidel A. Valea, Terrence K. Allen, Gloria Broadwater, Amy Bland, and Ashraf S. Habib. “Analgesic and antiemetic needs following minimally invasive vs open staging for endometrial cancer.” Am J Obstet Gynecol 204, no. 1 (January 2011): 65.e1-65.e6. https://doi.org/10.1016/j.ajog.2010.08.020.
    Full Text Link to Item
  - Morgan, Robert J., Ronald D. Alvarez, Deborah K. Armstrong, Barry Boston, Robert A. Burger, Lee-May Chen, Larry Copeland, et al. “Epithelial ovarian cancer.” J Natl Compr Canc Netw 9, no. 1 (January 2011): 82–113. https://doi.org/10.6004/jnccn.2011.0008.
    Full Text Link to Item
  - Sfakianos, Gregory P., and Laura J. Havrilesky. “A review of cost-effectiveness studies in ovarian cancer.” Cancer Control 18, no. 1 (January 2011): 59–64. https://doi.org/10.1177/107327481101800109.
    Full Text Link to Item
  - Wallace, Amy H., Laura J. Havrilesky, Fidel A. Valea, Jason C. Barnett, Andrew Berchuck, and Evan R. Myers. “Projecting the need for gynecologic oncologists for the next 40 years.” Obstet Gynecol 116, no. 6 (December 2010): 1366–72. https://doi.org/10.1097/AOG.0b013e3181fc3a22.
    Full Text Link to Item
  - Barnett, Jason C., John P. Judd, Jennifer M. Wu, Charles D. Scales, Evan R. Myers, and Laura J. Havrilesky. “Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer.” Obstet Gynecol 116, no. 3 (September 2010): 685–93. https://doi.org/10.1097/AOG.0b013e3181ee6e4d.
    Full Text Link to Item
  - Havrilesky, Laura J., Thomas C. Krivak, John W. Mucenski, and Evan R. Myers. “Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer.” Am J Obstet Gynecol 203, no. 2 (August 2010): 160.e1-160.e7. https://doi.org/10.1016/j.ajog.2010.02.054.
    Full Text Link to Item
  - Judd, John P., Nazema Y. Siddiqui, Jason C. Barnett, Anthony G. Visco, Laura J. Havrilesky, and Jennifer M. Wu. “Cost-minimization analysis of robotic-assisted, laparoscopic, and abdominal sacrocolpopexy.” J Minim Invasive Gynecol 17, no. 4 (2010): 493–99. https://doi.org/10.1016/j.jmig.2010.03.011.
    Full Text Link to Item
  - Jewell, Elizabeth L., Kathleen M. Darcy, Alan Hutson, Paula S. Lee, Laura J. Havrilesky, Lisa A. Grace, Andrew Berchuck, and Angeles Alvarez Secord. “Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.” Gynecol Oncol 115, no. 3 (December 2009): 424–29. https://doi.org/10.1016/j.ygyno.2009.07.035.
    Full Text Link to Item
  - Fader, Amanda Nickles, David Starks, Paola A. Gehrig, Angeles Alvarez Secord, Heidi E. Frasure, David M. O’Malley, Erin R. Tuller, et al. “An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).” Gynecol Oncol 115, no. 2 (November 2009): 244–48. https://doi.org/10.1016/j.ygyno.2009.07.030.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Laura J. Havrilesky, David M. O’Malley, Victoria Bae-Jump, Nicole D. Fleming, Gloria Broadwater, David E. Cohn, and Paola A. Gehrig. “A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.” Gynecol Oncol 114, no. 3 (September 2009): 442–47. https://doi.org/10.1016/j.ygyno.2009.06.005.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles Alvarez Secord, David M. O’Malley, Gloria Broadwater, Victoria Bae-Jump, David E. Cohn, and Paola A. Gehrig. “Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.” Gynecol Oncol 114, no. 2 (August 2009): 279–83. https://doi.org/10.1016/j.ygyno.2009.04.030.
    Full Text Link to Item
  - Bernardini, Marcus Q., Taymaa May, Mahmoud A. Khalifa, Amy E. Bland, Sharon Nofech-Mozes, Andrew Berchuck, Al Covens, and Laura Havrilesky. “Evaluation of two management strategies for preoperative grade 1 endometrial cancer.” Obstet Gynecol 114, no. 1 (July 2009): 7–15. https://doi.org/10.1097/AOG.0b013e3181aa97fc.
    Full Text Link to Item
  - Havrilesky, Laura J., G Larry Maxwell, and Evan R. Myers. “Cost-effectiveness analysis of annual screening strategies for endometrial cancer.” Am J Obstet Gynecol 200, no. 6 (June 2009): 640.e1-640.e8. https://doi.org/10.1016/j.ajog.2009.02.022.
    Full Text Link to Item
  - Fader, A. N., P. G. Rose, H. Frasure, P. A. Gehrig, K. N. Moore, L. J. Havrilesky, W. K. Huh, A. E. Axtell, D. M. O’Malley, and K. M. Zanotti. “Can primary recurrences in surgical stage I-II uterine papillary serous carcinoma (UPSC) patients be salvaged?” J Clin Oncol 27, no. 15_suppl (May 20, 2009): e16503.
    Link to Item
  - Fader, Amanda Nickles, Richard D. Drake, David M. O’Malley, Heidi E. Gibbons, Warner K. Huh, Laura J. Havrilesky, Paola A. Gehrig, et al. “Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.” Cancer 115, no. 10 (May 15, 2009): 2119–27. https://doi.org/10.1002/cncr.24247.
    Full Text Link to Item
  - Havrilesky, Laura J., Gloria Broadwater, Debra M. Davis, Kimberly C. Nolte, J Cory Barnett, Evan R. Myers, and Shalini Kulasingam. “Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.” Gynecol Oncol 113, no. 2 (May 2009): 216–20. https://doi.org/10.1016/j.ygyno.2008.12.026.
    Full Text Link to Item
  - Wu, Jennifer M., Nazema Y. Siddiqui, Cindy L. Amundsen, Evan R. Myers, Laura J. Havrilesky, and Anthony G. Visco. “Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.” J Urol 181, no. 5 (May 2009): 2181–86. https://doi.org/10.1016/j.juro.2009.01.037.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Victoria Bae-Jump, Laura J. Havrilesky, Brian Calingaert, Daniel L. Clarke-Pearson, John T. Soper, and Paola A. Gehrig. “Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.” Int J Gynecol Cancer 19, no. 3 (April 2009): 447–54. https://doi.org/10.1111/IGC.0b013e3181a1a6c9.
    Full Text Link to Item
  - Fader, Amanda Nickles, Christa Nagel, Allison E. Axtell, Kristine M. Zanotti, Joseph L. Kelley, Kathleen N. Moore, Angeles Alvarez Secord, et al. “Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.” Gynecol Oncol 112, no. 3 (March 2009): 558–62. https://doi.org/10.1016/j.ygyno.2008.11.016.
    Full Text Link to Item
  - Havrilesky, Laura J., G Larry Maxwell, John K. Chan, and Evan R. Myers. “Cost effectiveness of a test to detect metastases for endometrial cancer.” Gynecol Oncol 112, no. 3 (March 2009): 526–30. https://doi.org/10.1016/j.ygyno.2008.11.017.
    Full Text Link to Item
  - Neubauer, Nikki L., Laura J. Havrilesky, Brian Calingaert, Anuradha Bulusu, Marcus Q. Bernardini, Nicole D. Fleming, Amy E. Bland, and Angeles Alvarez Secord. “The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.” Gynecol Oncol 112, no. 3 (March 2009): 511–16. https://doi.org/10.1016/j.ygyno.2008.11.012.
    Full Text Link to Item
  - Rubatt, Jennifer M., Kathleen M. Darcy, Alan Hutson, Sarah M. Bean, Laura J. Havrilesky, Lisa A. Grace, Andrew Berchuck, and Angeles Alvarez Secord. “Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.” Gynecol Oncol 112, no. 3 (March 2009): 469–74. https://doi.org/10.1016/j.ygyno.2008.11.030.
    Full Text Link to Item
  - Havrilesky, L. J., N. D. Fleming, F. A. Valea, T. K. Allen, G. Broadwater, A. Bland, and A. Habib. “Minimally invasive staging for endometrial cancer is associated with lower pain, nausea and narcotic use.” Gynecologic Oncology 112, no. 2 (February 1, 2009): S80–S80.
    Link to Item
  - Havrilesky, L. J., T. C. Krivak, J. W. Mucenski, and E. R. Myers. “Cost analysis of ovarian cancer chemotherapy based on the use of a chemoresponse assay.” Gynecologic Oncology 112, no. 2 (February 1, 2009): S22–S22.
    Link to Item
  - Bland, Amy E., Brian Calingaert, Angeles Alvarez Secord, Paula S. Lee, Fidel A. Valea, Andrew Berchuck, John T. Soper, and Laura Havrilesky. “Relationship between tamoxifen use and high risk endometrial cancer histologic types.” Gynecol Oncol 112, no. 1 (January 2009): 150–54. https://doi.org/10.1016/j.ygyno.2008.08.035.
    Full Text Link to Item
  - Lee, Paula S., Amy Bland, Fidel A. Valea, Laura J. Havrilesky, Andrew Berchuck, and Angeles Alvarez Secord. “Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program.” Jsls 13, no. 4 (2009): 467–72. https://doi.org/10.4293/108680809X12589998403921.
    Full Text Link to Item
  - Havrilesky, Laura J., Gillian D. Sanders, Shalini Kulasingam, and Evan R. Myers. “Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?” Gynecol Oncol 111, no. 2 (November 2008): 179–87. https://doi.org/10.1016/j.ygyno.2008.07.006.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles Alvarez Secord, Kathleen M. Darcy, Deborah K. Armstrong, Shalini Kulasingam, and Shalini Gynecologic Oncology Group. “Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.” J Clin Oncol 26, no. 25 (September 1, 2008): 4144–50. https://doi.org/10.1200/JCO.2007.13.1961.
    Full Text Link to Item
  - Havrilesky, Laura J., Clark M. Whitehead, Jennifer M. Rubatt, Robert L. Cheek, John Groelke, Qin He, Douglas P. Malinowski, Timothy J. Fischer, and Andrew Berchuck. “Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.” Gynecol Oncol 110, no. 3 (September 2008): 374–82. https://doi.org/10.1016/j.ygyno.2008.04.041.
    Full Text Link to Item
  - Morgan, Robert J., Ronald D. Alvarez, Deborah K. Armstrong, Barry Boston, Lee-may Chen, Larry Copeland, Jeff Fowler, et al. “Ovarian cancer. Clinical practice guidelines in oncology.” J Natl Compr Canc Netw 6, no. 8 (September 2008): 766–94. https://doi.org/10.6004/jnccn.2008.0058.
    Full Text Link to Item
  - Lee, Paula S., Ryan Bakelaar, C Brennan Fitpatrick, Sarah C. Ellestad, Laura J. Havrilesky, and Angeles Alvarez Secord. “Medical and surgical treatment of placenta percreta to optimize bladder preservation.” Obstet Gynecol 112, no. 2 Pt 2 (August 2008): 421–24. https://doi.org/10.1097/AOG.0b013e31817e7966.
    Full Text Link to Item
  - Linkov, Faina, Zoya Yurkovetsky, Emanuela Taioli, Laura J. Havrilesky, G Larry Maxwell, and Anna Lokshin. “Endometrial cancer: multiplexed Luminex approaches for early detection.” Expert Opin Med Diagn 2, no. 5 (May 2008): 527–37. https://doi.org/10.1517/17530059.2.5.527.
    Full Text Link to Item
  - Havrilesky, L. J., G. Maxwell, and E. R. Myers. “Cost effectiveness of annual screening strategies for endometrial cancer.” Gynecologic Oncology 108, no. 3 (March 1, 2008): S7–S7.
    Link to Item
  - Havrilesky, L. J., S. Kulasingam, G. Sanders, and E. R. Myers. “Can screening for ovarian cancer achieve mortality reduction and be cost effective?” Gynecologic Oncology 108, no. 3 (March 1, 2008): S114–15.
    Link to Item
  - Kirkpatrick, John P., Zahid N. Rabbani, Rex C. Bentley, Matt E. Hardee, Seth Karol, Jeffrey Meyer, Egbert Oosterwijk, et al. “Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer.” Biomark Insights 3 (February 1, 2008): 45–55. https://doi.org/10.4137/bmi.s570.
    Full Text Link to Item
  - Jewell, Elizabeth L., Shalini Kulasingam, Evan R. Myers, Angeles Alvarez Secord, and Laura J. Havrilesky. “Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.” Gynecol Oncol 107, no. 3 (December 2007): 532–40. https://doi.org/10.1016/j.ygyno.2007.08.056.
    Full Text Link to Item
  - Zhang, Zhen, Yinhua Yu, Fengji Xu, Andrew Berchuck, Carolien van Haaften-Day, Laura J. Havrilesky, Henk W. A. de Bruijn, et al. “Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.” Gynecol Oncol 107, no. 3 (December 2007): 526–31. https://doi.org/10.1016/j.ygyno.2007.08.009.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Laura J. Havrilesky, Victoria Bae-Jump, Jeanette Chin, Brian Calingaert, Amy Bland, Teresa L. Rutledge, Andrew Berchuck, Daniel L. Clarke-Pearson, and Paola A. Gehrig. “The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.” Gynecol Oncol 107, no. 2 (November 2007): 285–91. https://doi.org/10.1016/j.ygyno.2007.06.014.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles Alvarez Secord, Shalini Kulasingam, and Evan Myers. “Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis.” Gynecol Oncol 107, no. 2 (November 2007): 211–18. https://doi.org/10.1016/j.ygyno.2007.06.029.
    Full Text Link to Item
  - Rankins, N Calloway, A Alvarez Secord, E. Jewell, L. J. Havrilesky, J. T. Soper, and E. Myers. “Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.” Gynecol Oncol 106, no. 2 (August 2007): 388–93. https://doi.org/10.1016/j.ygyno.2007.04.015.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Kathleen M. Darcy, Alan Hutson, Paula S. Lee, Laura J. Havrilesky, Lisa A. Grace, Andrew Berchuck, and Andrew Gynecologic Oncology Group study. “Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.” Gynecol Oncol 106, no. 1 (July 2007): 221–32. https://doi.org/10.1016/j.ygyno.2007.03.021.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles Alvarez Secord, Victoria Bae-Jump, Tina Ayeni, Brian Calingaert, Daniel L. Clarke-Pearson, Andrew Berchuck, and Paola A. Gehrig. “Outcomes in surgical stage I uterine papillary serous carcinoma.” Gynecol Oncol 105, no. 3 (June 2007): 677–82. https://doi.org/10.1016/j.ygyno.2007.01.041.
    Full Text Link to Item
  - Cohn, David E., Emily M. Woeste, Stacey Cacchio, Vanna L. Zanagnolo, Laura J. Havrilesky, Andrea Mariani, Karl C. Podratz, et al. “Clinical and pathologic correlates in surgical stage II endometrial carcinoma.” Obstet Gynecol 109, no. 5 (May 2007): 1062–67. https://doi.org/10.1097/01.AOG.0000260871.87607.25.
    Full Text Link to Item
  - Alvarez Secord, Angeles, Paola A. Gehrig, Laura J. Havrilesky, Victoria Bae-Jump, Jeannette Chin, Brian Calingaert, Amy Bland, Teresa Rutledge, Andrew Berchuck, and Daniel L. Clarke-Pearson. “The role of multimodality adjuvant chemotherapy and radiation in women with advanced-stage endometrial cancer.” Gynecologic Oncology 104, no. 3 (March 1, 2007): S6–S6.
    Link to Item
  - Havrilesky, Laura J., Clark Whitehead, Jennifer Rubatt, Robert L. Cheek, John Groelke, Qin He, Douglas P. Malinowski, Timothy J. Fischer, and Andrew Berchuck. “Preclinical evaluation of biomarkers for ovarian cancer detection and monitoring for disease recurrence.” Gynecologic Oncology 104, no. 3 (March 1, 2007): S12–S12.
    Link to Item
  - Havrilesky, Laura J., Janiel M. Cragun, Brian Calingaert, Angeles Alvarez Secord, Fidel A. Valea, Daniel L. Clarke-Pearson, Andrew Berchuck, and John T. Soper. “The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.” Gynecol Oncol 104, no. 2 (February 2007): 401–5. https://doi.org/10.1016/j.ygyno.2006.08.027.
    Full Text Link to Item
  - Secord, Angeles Alvarez, Laura J. Havrilesky, Michael E. Carney, John T. Soper, Daniel L. Clarke-Pearson, Gustavo C. Rodriguez, and Andrew Berchuck. “Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.” Int J Clin Oncol 12, no. 1 (February 2007): 31–36. https://doi.org/10.1007/s10147-006-0619-9.
    Full Text Link to Item
  - Huh, W. K., J. M. Straughn, A. Mariani, K. C. Podratz, L. J. Havrilesky, A. Alvarez-Secord, M. A. Gold, et al. “Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.” Int J Gynecol Cancer 17, no. 4 (2007): 886–89. https://doi.org/10.1111/j.1525-1438.2007.00858.x.
    Full Text Link to Item
  - Soper, J. T., A. A. Secord, L. J. Havrilesky, A. Berchuck, and D. L. Clarke-Pearson. “Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity.” Int J Gynecol Cancer 17, no. 1 (2007): 298–303. https://doi.org/10.1111/j.1525-1438.2007.00784.x.
    Full Text Link to Item
  - Myers, Evan R., Laura J. Havrilesky, Shalini L. Kulasingam, Gillian D. Sanders, Kathryn E. Cline, Rebecca N. Gray, Andrew Berchuck, and Douglas C. McCrory. “Genomic tests for ovarian cancer detection and management.” Evid Rep Technol Assess (Full Rep), no. 145 (October 2006): 1–100.
    Link to Item
  - Lutman, Christopher V., Laura J. Havrilesky, Janiel M. Cragun, Angeles Alvarez Secord, Brian Calingaert, Andrew Berchuck, Daniel L. Clarke-Pearson, and John T. Soper. “Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.” Gynecol Oncol 102, no. 1 (July 2006): 92–97. https://doi.org/10.1016/j.ygyno.2005.11.032.
    Full Text Link to Item
  - Alvarez Secord, A., L. J. Havrilesky, R. V. Higgins, L. R. Nycum, M. F. Kohler, L. E. Puls, R. Holloway, J. T. Soper, F. A. Valea, and A. Berchuck. “A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 5092.
    Link to Item
  - Gynecologic Oncology Group, Andrew, Angeles Alvarez Secord, Paula S. Lee, Kathleen M. Darcy, Laura J. Havrilesky, Lisa A. Grace, Jeffrey R. Marks, and Andrew Berchuck. “Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.” Gynecol Oncol 101, no. 3 (June 2006): 390–97. https://doi.org/10.1016/j.ygyno.2006.02.014.
    Full Text Link to Item
  - Myers, Evan R., Lori A. Bastian, Laura J. Havrilesky, Shalini L. Kulasingam, Mishka S. Terplan, Kathryn E. Cline, Rebecca N. Gray, and Douglas C. McCrory. “Management of adnexal mass.” Evid Rep Technol Assess (Full Rep), no. 130 (February 2006): 1–145.
    Link to Item
  - Havrilesky, Laura J., Janiel M. Cragun, Brian Calingaert, Ingrid Synan, Angeles Alvarez Secord, John T. Soper, Daniel L. Clarke-Pearson, and Andrew Berchuck. “Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.” Gynecol Oncol 99, no. 3 (December 2005): 689–95. https://doi.org/10.1016/j.ygyno.2005.07.014.
    Full Text Link to Item
  - Alvarez Secord, A., E. L. Jones, C. A. Hahn, W. P. Petros, D. Yu, L. J. Havrilesky, J. T. Soper, et al. “Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.” Int J Hyperthermia 21, no. 4 (June 2005): 333–47. https://doi.org/10.1080/02656730500110155.
    Full Text Link to Item
  - Cragun, Janiel M., Laura J. Havrilesky, Brian Calingaert, Ingrid Synan, Angeles Alvarez Secord, John T. Soper, Daniel L. Clarke-Pearson, and Andrew Berchuck. “Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.” J Clin Oncol 23, no. 16 (June 1, 2005): 3668–75. https://doi.org/10.1200/JCO.2005.04.144.
    Full Text Link to Item
  - Soper, John T., Angeles Alvarez Secord, Laura J. Havrilesky, Andrew Berchuck, and Daniel L. Clarke-Pearson. “Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity.” Gynecol Oncol 97, no. 2 (May 2005): 596–601. https://doi.org/10.1016/j.ygyno.2005.01.032.
    Full Text Link to Item
  - Havrilesky, Laura J., Shalini L. Kulasingam, David B. Matchar, and Evan R. Myers. “FDG-PET for management of cervical and ovarian cancer.” Gynecol Oncol 97, no. 1 (April 2005): 183–91. https://doi.org/10.1016/j.ygyno.2004.12.007.
    Full Text Link to Item
  - Soper, J. T., L. J. Havrilesky, A. A. Secord, A. Berchuck, and D. L. Clarke-Pearson. “Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery.” Int J Gynecol Cancer 15, no. 3 (2005): 542–48. https://doi.org/10.1111/j.1525-1438.2005.15322.x.
    Full Text Link to Item
  - Skates, Steven J., Nora Horick, Yinhua Yu, Feng-Ji Xu, Andrew Berchuck, Laura J. Havrilesky, Henk W. A. de Bruijn, et al. “Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.” J Clin Oncol 22, no. 20 (October 15, 2004): 4059–66. https://doi.org/10.1200/JCO.2004.03.091.
    Full Text Link to Item
  - Berchuck, A., A. A. Secord, L. J. Havrilesky, R. Wenham, J. T. Soper, and D. L. Clarke-Pearson. “Phase I/II trial of combination topotecan and vinorelbine in patients with refractory gynecologic cancer.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 5152.
    Link to Item
  - Secord, A. A., E. Jones, C. A. Hahn, L. J. Havrilesky, J. T. Soper, A. Berchuck, D. L. Clarke-Pearson, L. R. Prosnitz, and M. W. Dewhirst. “Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 5089.
    Link to Item
  - Havrilesky, Laura J., Charles A. Leath, Warner Huh, Brian Calingaert, Rex C. Bentley, John T. Soper, and Angeles Alvarez Secord. “Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.” Gynecol Oncol 93, no. 2 (May 2004): 429–34. https://doi.org/10.1016/j.ygyno.2004.01.038.
    Full Text Link to Item
  - Lancaster, Johnathan M., Holly K. Dressman, Regina S. Whitaker, Laura Havrilesky, Jonathan Gray, Jeffrey R. Marks, Joseph R. Nevins, and Andrew Berchuck. “Gene expression patterns that characterize advanced stage serous ovarian cancers.” J Soc Gynecol Investig 11, no. 1 (January 2004): 51–59. https://doi.org/10.1016/j.jsgi.2003.07.004.
    Full Text Link to Item
  - Havrilesky, Laura, kathleen M. Darcy, Hasnah Hamdan, Roger L. Priore, Jorge Leon, Jeffrey Bell, Andrew Berchuck, and Andrew Gynecologic Oncology Group Study. “Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.” J Clin Oncol 21, no. 20 (October 15, 2003): 3814–25. https://doi.org/10.1200/JCO.2003.11.052.
    Full Text Link to Item
  - Roth, Ted M., Angeles Alvarez Secord, Laura J. Havrilesky, Ellen Jones, and Daniel L. Clarke-Pearson. “High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.” Gynecol Oncol 91, no. 1 (October 2003): 258–60. https://doi.org/10.1016/s0090-8258(03)00443-8.
    Full Text Link to Item
  - Havrilesky, Laura J., Bercedis L. Peterson, Damla K. Dryden, John T. Soper, Daniel L. Clarke-Pearson, and Andrew Berchuck. “Predictors of clinical outcomes in the laparoscopic management of adnexal masses.” Obstet Gynecol 102, no. 2 (August 2003): 243–51. https://doi.org/10.1016/s0029-7844(03)00480-0.
    Full Text Link to Item
  - Jones, Ellen L., Thaddeus V. Samulski, Mark W. Dewhirst, Angeles Alvarez-Secord, Andrew Berchuck, Daniel Clarke-Pearson, Laura J. Havrilesky, John Soper, and Leonard R. Prosnitz. “A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.” Cancer 98, no. 2 (July 15, 2003): 277–82. https://doi.org/10.1002/cncr.11475.
    Full Text Link to Item
  - Havrilesky, Laura J., Terence Z. Wong, Angeles Alvarez Secord, Andrew Berchuck, Daniel L. Clarke-Pearson, and Ellen L. Jones. “The role of PET scanning in the detection of recurrent cervical cancer.” Gynecol Oncol 90, no. 1 (July 2003): 186–90. https://doi.org/10.1016/s0090-8258(03)00256-7.
    Full Text Link to Item
  - Havrilesky, Laura J., Angeles A. Alvarez, Robyn A. Sayer, Johnathan M. Lancaster, John T. Soper, Andrew Berchuck, Daniel L. Clarke-Pearson, Gustavo C. Rodriguez, and Michael E. Carney. “Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.” Gynecol Oncol 88, no. 1 (January 2003): 51–57. https://doi.org/10.1006/gyno.2002.6859.
    Full Text Link to Item
  - Lancaster, J. M., L. J. Havrilesky, and A. Berchuck. “The Genetic Etiology of Sporadic Ovarian Cancer,” January 1, 2003, 139–55. https://doi.org/10.1016/B978-012053642-9/50016-8.
    Full Text
  - Havrilesky, L. J., A. A. Alvarez, R. S. Whitaker, J. R. Marks, and A. Berchuck. “Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.” Gynecol Oncol 83, no. 3 (December 2001): 491–500. https://doi.org/10.1006/gyno.2001.6464.
    Full Text Link to Item
  - Haaften-Day, C. van, Y. Shen, F. Xu, Y. Yu, A. Berchuck, L. J. Havrilesky, H. W. de Bruijn, A. G. van der Zee, R. C. Bast, and N. F. Hacker. “OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.” Cancer 92, no. 11 (December 1, 2001): 2837–44. https://doi.org/10.1002/1097-0142(20011201)92:11<2837::aid-cncr10093>3.0.co;2-5.
    Full Text Link to Item
  - Havrilesky, L. J., C. P. McMahon, E. K. Lobenhofer, R. Whitaker, J. R. Marks, and A. Berchuck. “Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.” J Soc Gynecol Investig 8, no. 2 (2001): 104–13.
    Link to Item
  - Havrilesky, L. J., A. Elbendary, J. A. Hurteau, R. S. Whitaker, G. C. Rodriguez, and A. Berchuck. “Chemotherapy-induced apoptosis in epithelial ovarian cancers.” Obstet Gynecol 85, no. 6 (June 1995): 1007–10. https://doi.org/10.1016/0029-7844(95)00058-y.
    Full Text Link to Item
  - Havrilesky, L. J., J. A. Hurteau, R. S. Whitaker, A. Elbendary, S. Wu, G. C. Rodriguez, R. C. Bast, and A. Berchuck. “Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.” Cancer Res 55, no. 4 (February 15, 1995): 944–48.
    Link to Item
  - Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, J. D. Iglehart, and J. R. Marks. “Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.” Cell Growth Differ 5, no. 12 (December 1994): 1301–7.
    Link to Item
  - Berchuck, A., A. Elbendary, L. Havrilesky, G. C. Rodriguez, and R. C. Bast. “Pathogenesis of ovarian cancers.” J Soc Gynecol Investig 1, no. 3 (1994): 181–90. https://doi.org/10.1177/107155769400100302.
    Full Text Link to Item
- Book Sections
  - Watson, C. H., F. A. Valea, and L. J. Havrilesky. “Evidence-based medicine and clinical epidemiology.” In Comprehensive Gynecology, 2021. https://doi.org/10.1016/B978-0-323-65399-2.00014-0.
    Full Text
  - Havrilesky, L. J., S. L. Kulasingam, E. L. Jewell, and D. E. Cohn. “Comparative effectiveness research in gynecologic oncology.” In Principles and Practice of Gynecologic Oncology: Sixth Edition, 503–17, 2013.
  - Havrilesky, L. J., A. Mendivil, and D. L. Clarke-Pearson. “Palliative surgery for ovarian cancer.” In Surgery for Ovarian Cancer: Principles and Practice, 250–66, 2010. https://doi.org/10.3109/9781841847825.
    Full Text
- Conference Papers
  - Wong, J., R. Gonzalez, B. Albright, T. Hayes, A. Swartz, L. J. Havrilesky, P. S. Lee, and R. A. Previs. “Telemedicine and gynecologic oncology: caring for patients remotely during a global pandemic.” In Ajog Global Reports, Vol. 2, 2022. https://doi.org/10.1016/j.xagr.2022.100124.
    Full Text
  - Konski, Andre A., Laura Jean Havrilesky, Elizabeth Lin Jewell, and Jason A. Efstathiou. “Radiotherapy use in the treatment of gastrointestinal cancers in Medicare patients: An analysis of a CMS database.” In Journal of Clinical Oncology, Vol. 38, 2020.
    Link to Item
  - Havrilesky, L. J., S. L. Lim, J. A. Ehrisman, A. Lorenzo, Alvarez A. Secord, J. C. Yang, F. R. Johnson, and S. D. Reed. “WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER.” In Value in Health, 22:S541–S541. ELSEVIER SCIENCE INC, 2019.
    Link to Item
  - Hendrickson-Cahill, W. K., L. J. Havrilesky, and N. Y. Siddiqui. “COST EFFECTIVENESS OF SELECTIVE COMPARED TO UNIVERSAL URINE SCREENING PROTOCOL PRIOR TO UROGYNECOLOGIC SURGERY.” In International Urogynecology Journal, 30:S177–78. SPRINGER LONDON LTD, 2019.
    Link to Item
  - Watson, Catherine H., Allison Puechl, Truong Tracy, Stephanie Lim, Laura Jean Havrilesky, and Brittany Anne Davidson. “Therapy discontinuation processes in a gynecologic oncology population.” In Journal of Clinical Oncology, Vol. 37. AMER SOC CLINICAL ONCOLOGY, 2019.
    Link to Item
  - Havrilesky, Laura Jean, Stephanie Lim, Jui-Chen Yang, Amelia Lorenzo, Jessie A. Ehrisman, Angeles Alvarez Secord, Reed Johnson, and Shelby D. Reed. “Patient preferences for maintenance PARP therapy in ovarian cancer treatment.” In Journal of Clinical Oncology, 37:5558–5558. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5558.
    Full Text
  - Watson, Catherine H., Brittany Anne Davidson, Laura Jean Havrilesky, Paula S. Lee, Leah McNally, Haley Moss, Rebecca A. Previs, et al. “Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns.” In Journal of Clinical Oncology, 37:1536–1536. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.1536.
    Full Text
  - Reed, S., J. C. Yang, J. A. Ehrisman, S. L. Lim, and L. J. Havrilesky. “PNS232 ARE VIDEOS OR TEXT BETTER FOR DESCRIBING ATTRIBUTES IN STATED-PREFERENCE SURVEYS? SOME EXPERTS WILL BE SURPRISED.” In Value in Health, 22:S325–S325. Elsevier BV, 2019. https://doi.org/10.1016/j.jval.2019.04.1588.
    Full Text
  - Lim, S. L., L. J. Havrilesky, R. P. Heine, and S. Dotters-Katz. “The cost-effectiveness of ertapenem for the treatment of chorioamnionitis after cesarean section.” In American Journal of Obstetrics and Gynecology, 219:650–650. Elsevier BV, 2018. https://doi.org/10.1016/j.ajog.2018.10.052.
    Full Text
  - Davidson, B. A., J. Ehrisman, S. D. Reed, J. Yang, F. R. Johnson, A. H. Buchanan, P. K. Marcom, and L. J. Havrilesky. “PMD180 - THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE: A DISCRETE CHOICE EXPERIMENT.” In Value in Health, 21:S274–S274. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.09.1629.
    Full Text
  - Gaillard, Stephanie, Laurie M. Gay, Meghan Steiner, Kaitlyn Andreano, Brittany Anne Davidson, Laura Jean Havrilesky, Angeles Alvarez Secord, et al. “Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies.” In Journal of Clinical Oncology, 36:5590–5590. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5590.
    Full Text
  - Lim, Stephanie, Allison Puechl, Gloria Broadwater, Jessie Ehrisman, Amelia Lorenzo, Jonathan Foote, Brittany Anne Davidson, Junzo P. Chino, and Laura Jean Havrilesky. “Variability in Medicare utilization and payment among gynecologic oncologists.” In Journal of Clinical Oncology, 36:5599–5599. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5599.
    Full Text
  - Chino, Fumiko, Gita Suneja, Haley Moss, S Yousuf Zafar, Laura Havrilesky, and Junzo Chino. “Health Care Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status After Medicaid Expansion Under the Affordable Care Act.” In Int J Radiat Oncol Biol Phys, 101:9–20, 2018. https://doi.org/10.1016/j.ijrobp.2017.12.006.
    Full Text Link to Item
  - Foote, Jonathan, Laura Jean Havrilesky, Elizabeth Lin Jewell, Charlotte Gamble, Jessie Ehrisman, Gloria Broadwater, Robert L. Coleman, David E. Cohn, and Angeles Alvarez Secord. “Management of platinum-sensitive recurrent ovarian cancer (PSROC) in the era of biologics: Can ASCO’s net health benefits (NHB) inform our decisions?” In Journal of Clinical Oncology, 35:5544–5544. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.5544.
    Full Text
  - Gaillard, Stephanie, Chelsae Dumbauld, Alyssa Bilewski, Jessie A. Ehrisman, Angeles Alvarez Secord, Laura Jean Havrilesky, Andrew Berchuck, Kent Weinhold, Cliburn Chan, and John Yi. “Evaluating the repertoire of immune checkpoint markers expressed on peripheral and ascites CD8⁺ T cells in ovarian cancer.” In Journal of Clinical Oncology, 35:5571–5571. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.5571.
    Full Text
  - Moss, Haley, Evan Myers, Andrew Berchuck, and Laura Jean Havrilesky. “Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective.” In Journal of Clinical Oncology, 35:6608–6608. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.6608.
    Full Text
  - Wenzel, Lari B., Dana B. Mukamel, Kathryn Osann, Lisa Sparks, Laura Jean Havrilesky, Alexi A. Wright, Joan L. Walker, et al. “Shared decision-making in ovarian cancer.” In Journal of Clinical Oncology, 35:5549–5549. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.5549.
    Full Text
  - Davidson, Brittany Anne, Robert Squatrito, Linda R. Duska, Laura Jean Havrilesky, Nyssa Schwager, Michael McCollum, Sanja Arapovic, and Angeles Alvarez Secord. “Phase II evaluation of nintedanib in the treatment of bevacizumab-resistant persistent/recurrent ovarian, fallopian tube, or primary peritoneal carcinoma.” In Journal of Clinical Oncology, 34:TPS5601–TPS5601. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.tps5601.
    Full Text
  - Foote, Jonathan, Margaret Liang, Angeles Alvarez Secord, David E. Cohn, and Laura Jean Havrilesky. “Patient preference-weighted assessments using the ASCO value framework in recurrent, platinum-sensitive ovarian cancer.” In Journal of Clinical Oncology, 34:6630–6630. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.6630.
    Full Text
  - Hong, Julian C., Jonathan Foote, Laura Jean Havrilesky, Stephanie Gaillard, and Junzo P. Chino. “Chemotherapy and radiotherapy in early stage uterine papillary serous and clear-cell carcinoma: A National Cancer Data Base study.” In Journal of Clinical Oncology, 34:5590–5590. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.5590.
    Full Text
  - Ehrisman, Jessie A., Sara Abbott, Zach Harmon, Angeles Alvarez Secord, Andrew Berchuck, Paula S. Lee, Fidel A. Valea, et al. “Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-Grade Endometrial Cancer.” In Modern Pathology, 29:282A-282A. NATURE PUBLISHING GROUP, 2016.
    Link to Item
  - Davidson, B. A., D. B. Mannschreck, G. Broadwater, M. Lopez-Acevedo, P. S. Lee, L. J. Havrilesky, F. A. Valea, A. Berchuck, and A. A. Secord. “Findings at laparoscopy, not debulking status, are associated with survival in advanced stage ovarian cancer after neoadjuvant chemotherapy.” In Gynecologic Oncology, 137:111–111. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.276.
    Full Text
  - Dottino, J. A., B. A. Cliby, E. R. Myers, R. E. Bristow, and L. J. Havrilesky. “Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.” In Gynecologic Oncology, 137:188–89. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.473.
    Full Text
  - Ehrisman, J. A., A. A. Secord, A. Berchuck, P. S. Lee, N. Di Santo, F. A. Valea, and L. J. Havrilesky. “Sentinel lymph node mapping in women with high risk histology endometrial cancer.” In Gynecologic Oncology, 137:93–93. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.229.
    Full Text
  - Forde, B., J. Wallbillich, L. J. Havrilesky, and D. E. Cohn. “A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy.” In Gynecologic Oncology, 137:24–24. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.056.
    Full Text
  - Lopez-Acevedo, M., A. H. Buchanan, A. A. Secord, P. S. Lee, C. Fountain, E. R. Myers, D. E. Cohn, S. D. Reed, and L. J. Havrilesky. “Cost comparison among different genetic testing strategies in women with epithelial ovarian cancer.” In Gynecologic Oncology, 137:171–171. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.429.
    Full Text
  - Miller, C. R., N. P. Chappell, C. A. Leath, N. T. Phippen, L. J. Havrilesky, and J. C. Barnett. “Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?” In Gynecologic Oncology, 137:170–170. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.427.
    Full Text
  - Teoh, Deanna, William J. Lowery, Xiaoyin Jiang, Jessie Ehrisman, Paige Halvorson, Gloria Broadwater, Rex Bentley, et al. “Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial.” In J Minim Invasive Gynecol, 22:227–33, 2015. https://doi.org/10.1016/j.jmig.2014.10.002.
    Full Text Link to Item
  - Doll, Kemi Morenikeji, Ke Meng, Ethan M. Basch, Paola A. Gehrig, Laura Jean Havrilesky, Wendy R. Brewster, and Anne-Marie Meyer. “Geographic variation in high-risk uterine cancer histology and access to care.” In Journal of Clinical Oncology, 32:e16546–e16546. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e16546.
    Full Text
  - Havrilesky, Laura Jean, Angeles Alvarez Secord, Jessie A. Ehrisman, Andrew Berchuck, Fidel A. Valea, Paula S. Lee, Stephanie Gaillard, et al. “Relative influence of factors determining a woman’s preference for treatment options in ovarian cancer.” In Journal of Clinical Oncology, 32:5544–5544. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.5544.
    Full Text
  - Roque, Dario R., Stuart Pierce, Kemi Morenikeji Doll, Brittany Davidson, Amanda Lynn Jackson, Emily Meichun Ko, Dominic T. Moore, et al. “Endometrial cancer outcomes in hypertensive women treated with beta-blocker.” In Journal of Clinical Oncology, 32:e16545–e16545. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e16545.
    Full Text
  - Havrilesky, L. J., A. A. Secord, J. Ehrisman, A. Berchuck, F. A. Valea, P. S. Lee, D. Cella, K. Weinfurt, A. P. Abernethy, and S. D. Reed. “Relative Influence of Factors Determining a Woman’s Preference for Treatment Options in Ovarian Cancer: A Discrete Choice Experiment.” In Value in Health, 17:A93–A93. Elsevier BV, 2014. https://doi.org/10.1016/j.jval.2014.03.539.
    Full Text
  - Ko, Emily Meichun, Paige Walter, Leslie Horn Clark, Amanda Lynn Jackson, Jason Franasiak, Laura Jean Havrilesky, Angeles Alvarez Secord, Dominic T. Moore, Paola A. Gehrig, and Victoria Lin Bae-Jump. “The impact of diabetes and obesity on endometrial cancer outcomes.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Stine, Jessica E., Stuart Pierce, Paola A. Gehrig, John Nakayama, Laura Jean Havrilesky, Angeles Alvarez Secord, Wing K. Chiu, Dominic T. Moore, and Kenneth H. Kim. “Recurrence rates in patients with uterine papillary serous cancer with and without breast cancer.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Havrilesky, L. J., R. K. Hanna, M. S. Poniewierski, R. Laskey, A. A. Secord, P. A. Gehrig, M. A. Lopez, et al. “Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.” In Journal of Clinical Oncology, 29:5084–5084. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.5084.
    Full Text
  - Fader, A Nickles, P. G. Rose, H. Frasure, P. A. Gehrig, K. N. Moore, L. J. Havrilesky, W. K. Huh, A. E. Axtell, D. M. O’Malley, and M. Zanotti. “Can primary recurrences in surgical stage I-II uterine papillary serous carcinoma (UPSC) patients be salvaged?” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
    Link to Item
  - Fader, A Nickles, D. Starks, P. G. Rose, E. R. Tuller, H. Gibbons, P. A. Gehrig, W. K. Huh, et al. “Early-stage uterine papillary serous carcinoma (UPSC): percentage UPSC, lymphvascular invasion and tumor size are not independent predictors of recurrence.” In Gynecologic Oncology, 112:S72–73. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009.
    Link to Item
  - Havrilesky, L. J., A Alvarez Secord, D. M. O’Malley, V. Bae-Jump, G. Broadwater, J. Tatagari, N. Hamamci, and P. A. Gehrig. “Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.” In Gynecologic Oncology, 112:S81–S81. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009.
    Link to Item
  - Secord, A Alvarez, L. J. Havrilesky, D. M. O’Malley, V. Bae-Jump, N. D. Fleming, G. Broadwater, D. E. Cohn, and P. A. Gehrig. “A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.” In Gynecologic Oncology, 112:S12–13. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009.
    Link to Item
  - Secord, A Alvarez, N. Neubauer, L. J. Havrilesky, B. Calingaert, M. Bernardini, A. Bland, and N. Fleming. “The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.” In Gynecologic Oncology, 112:S91–92. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009.
    Link to Item
  - Shafer, A., T. A. Ayeni, A. M. Deal, A Alvarez Secord, J. T. Soper, L. J. Havrilesky, L. Van Le, and P. A. Gehrig. “Improved survival with consolidation chemotherapy after adjuvant paclitaxel and carboplatin in advanced epithelial ovarian cancer.” In Gynecologic Oncology, 112:S135–36. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2009.
    Link to Item
  - Rubatt, J. M., K. M. Darcy, A. Hutson, S. M. Bean, L. J. Havrilesky, P. S. Lee, L. A. Grace, A. Berchuck, and A Alvarez Secord. “Prognostic relevance of microvessel density in previously untreated, advanced-stage epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.” In Gynecologic Oncology, 108:S20–S20. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2008.
    Link to Item
  - Shafer, A., J. M. Rubatt, T. Ayeni, A. M. Deal, A. A. Secord, J. T. Soper, L. J. Havrilesky, L. Van Le, and P. A. Gehring. “Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer.” In Gynecologic Oncology, 108:S55–56. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2008.
    Link to Item
  - Jones, E. L., L. J. Havrilesky, A. A. Secord, D. L. Clarke-Pearson, J. T. Soper, F. Valea, R. E. Coleman, and T. Z. Wong. “68.” In International Journal of Radiation Oncology*Biology*Physics, 66:S40–S40. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.098.
    Full Text
  - Secord, A Alvarez, L. J. Havrilesky, R. V. Higgins, L. R. Nycum, M. F. Kohler, L. E. Puls, R. Holloway, J. T. Soper, F. A. Valea, and A. Berchuck. “A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” In Journal of Clinical Oncology, 24:278S-278S. AMER SOC CLINICAL ONCOLOGY, 2006.
    Link to Item
  - Rabbani, Z. N., J. P. Kirkpatrick, F. K. Salahuddin, R. C. Bentley, A. A. Secord, C. S. Greenberg, L. J. Havrilesky, Z. Vujaskovic, E. Jones, and M. W. Dewhirst. “Tissue transglutaminase expression in early-stage cervical cancer.” In International Journal of Radiation Oncology Biology Physics, 66:S167–S167, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.331.
    Full Text Link to Item
  - Berchuck, A., A. A. Secord, L. J. Havrilesky, R. Wenham, J. T. Soper, and D. L. Clarke-Pearson. “Phase I/II trial of combination topotecan and vinorelbine in patients with refractory gynecologic cancer.” In Journal of Clinical Oncology, 22:487S-487S. AMER SOC CLINICAL ONCOLOGY, 2004.
    Link to Item
  - Secord, A. A., E. Jones, C. A. Hahn, L. J. Havrilesky, J. T. Soper, A. Berchuck, D. L. Clarke-Pearson, and L. R. Prosnitz. “Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer.” In Journal of Clinical Oncology, 22:471S-471S. AMER SOC CLINICAL ONCOLOGY, 2004.
    Link to Item
Teaching & Mentoring
Advising & Mentoring
- I am actively involved in mentoring medical students, residents and fellows. I serve as Director of Resident Research for the Department of Obstetrics and Gynecology. I have been a mentor for over 40 students, residents, fellows and junior faculty engaged in one or multiple research projects, the vast majority of which have been presented at national or regional meetings and/or published in peer-review journals.
  
  I oversee Health Services Research in the Division of Gynecologic Oncology. As such, I oversee a biweekly research meeting that includes 4 faculty, 1 research fellow, and 3-4 medical students currently doing research in our division. These meetings include project updates as well as faculty lectures on research topics such as Elevator talks, Writing a manuscript, Oral presentations, and Responding to reviewer comments.
Teaching Activities
- As a director of resident research in the Department of Obstetrics and Gynecology at Duke, I co-designed a didactic research education curriculum for trainees. This is a core 12 lecture series delivered over a 2 year time frame, and includes the following topics: the nuts and bolts of research, literature search/reference management, regulatory aspects of research, trainee research grant application and management, basic study designs, clinical study metrics, communicating with statisticians, basic science/translational research topics, qualitative research, quality improvement versus research, how to give research presentations, publication of research, and how to respond to reviewer comments.
  
  I currently teach LIC program medical students in my weekly gynecologic oncology clinics at Macon Pond.
Scholarly, Clinical, & Service Activities
Presentations & Appearances
- Course director. Educational forum: Health economics and payment reform. Society of Gynecologic Oncology. 2018 2018
- Course director. Educational forum: How to define and deliver value-based care in gynecologic cancer. Society of Gynecologic Oncology. 2016 2016
Outreach & Engaged Scholarship
- Co-Chair. Payment Reform Taskforce. Society of Gynecologic Oncology. 2016 - 2019 2016 - 2019
Service to the Profession
Service to Duke
Academic & Administrative Activities
- I am co-Director of Resident Research in the Department of Obstetrics and Gynecology and Director of Health Services Research in the Division of Gynecologic Oncology.
Clinical Activities
- My gynecologic oncology clinical practice consists of 7-8 outpatient clinic days per month: 2-3 days at Duke and 4-5 days at the Duke Raleigh Macon Pond office. I have one operating room day per week at Duke North. I am on call for the inpatient Gynecologic Oncology service approximately one out of every five weeks and take general Gynecology call one night per month.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Leadership & Clinical Positions at Duke

Academic Positions Outside Duke

Awards & Honors

Selected Grants

Selected Publications

Academic Articles

Book Sections

Conference Papers

Advising & Mentoring

Teaching Activities

Presentations & Appearances

Outreach & Engaged Scholarship

Service to the Profession

Service to Duke

Academic & Administrative Activities

Clinical Activities